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 Abstract 
Hypericum perforatum, known as St. John´s wort, is one of the most famous and best 
investigated medicinal plants. It is commonly used for the treatment of mild to moderate 
depression. Hyperforin was identified as an important constituent to be responsible for 
the major pharmaceutical effects of the extract. However, it is a light, oxygen, and 
temperature sensitive hydrophobic acylphloroglucinol derivative with one geranyl and 
several prenyl side chains. Its biosynthetic pathway is not yet completely understood. 
As proposed, the biosynthesis of hyperforin starts with the formation of the core 
structure, phlorisobutyrophenone (PIBP), catalyzed by a type III polyketide synthase. 
The subsequent decoration of PIBP with the prenyl and geranyl groups is catalyzed by 
membrane-bound aromatic prenyltransferase (PT) enzymes.  
The aim of the present project was the identification and characterization of enzymes 
that are involved in hyperforin biosynthesis. Four consecutive enzymes encoding an 
acyl-CoA ligase (HpIBCL), an isobutyrophenone synthase (HpIBS) and two successive 
PTs were functionally expressed in Saccharomyces cerevisiae. The first step was the 
de novo biosynthesis of the hyperforin skeleton PIBP. Therefore, cDNAs encoding 
HpIBCL and HpIBS had been cloned from H. perforatum. Feeding isobutyric acid to S. 
cerevisiae harboring either episomal or genome-integrated HpIBCL and HpIBS 
resulted in the formation of intracellular and extracellular PIBP.  
In total, twelve PTs were individually expressed in S. cerevisiae. One PT (HpPT2) was 
identified to catalyze the GPP-dependent geranylation of acylphloroglucinol 
derivatives, preferably PIBP and 2-methylbutyrophenone (2-MBP). A second PT 
(HpPT6) catalyzed the addition of one prenyl group to the HpPT2 product, forming the 
hyperforin precursor 3-geranyl-5-prenyl-PIBP. The biochemical properties of both PTs 
were further characterized. They showed typical characteristics of plant-derived PTs, 
such as dependency on divalent cations, alkaline pH optimum, and the relatively broad 
acceptor substrate specificity. The KM values of HpPT2 for 2-MBP and PIBP were 85 
± 15 µM and 124 ± 19 µM, respectively. The KM values of HpPT6 for 3-geranyl-2-MBP, 
3-geranyl-PIVP, and 3-geranyl-PIBP were 73 ± 10, 78 ± 8.6, and 181 ± 218, 
respectively. These results confirm the identification of the first PT enzymes involved 
in hyperforin biosynthesis. Formation of the hyperforin precursor by HpPT2 and HpPT6 
in S. cerevisiae stimulates further research efforts into this promising approach. 
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1. Introduction 
1.1. White and red biotechnology, the new era  
Biotechnology involves the application of organisms such as bacteria, yeast cells and 
plants to manufacture and/or modify products for commercial purposes. 
Biotechnological production processes have many advantages compared to chemical 
manufacturing processes. Especially the usability of renewable resources instead of 
fossil raw materials is expected to completely change many future manufacturing 
processes 1.  
Many different industrial branches discover and elevate the potential of e.g. microbial 
fermentation processes to produce nutraceuticals, cosmetics, flavors, fragrances, 
lubricants, fuels, and polymers 2–6. The use of microbial biocatalyst has many attractive 
advantages compared to chemical catalysis. This involves environmentally friendly 
reaction conditions such as low temperature, atmospheric pressure and neutral pH. 
Additionally, microorganisms can produce highly valuable and complex structures, 
which would require multiple reaction steps in chemical synthesis processes. The 
major bottleneck using microbial production processes is still the low product yield. The 
commonly used microbial production hosts are Escherichia coli (E. coli) and the 
baker´s yeast (Saccharomyces cerevisiae) 7.  
S. cerevisiae is one of the most interesting and most commonly used eukaryotic 
organisms for industrial production processes. It belongs to the best-investigated 
organisms regarding its metabolic profile, molecular genetic tools, and experience with 
cultivation methods. Furthermore, it is tolerant against low pH and stable against 
autolysis 8. This enables cultivations at low pH to reduce the risk of contamination and 
facilitates long cultivation processes. Nowadays, S. cerevisiae is used for the 
production of a large variety of different compounds such as proteins, foods, 
beverages, bulk chemicals, biofuels, pharmaceuticals, and plant secondary 
metabolites 9.  
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1.2. Plant secondary metabolites 
Many plant secondary metabolites are useful and highly valuable compounds with a 
broad range of applications as pharma- and nutraceuticals 10. They are divided into 
three main classes based on their biosynthetic pathways: 1) (poly-) phenols derived 
from the malonate (polyketide) pathway and/or shikimate pathway, 2) terpenoids 
derived from the mevalonic acid (MVA) pathway and/or the methylerythritol phosphate 
(MEP) pathway, and 3) nitrogen-containing constituents (alkaloids) derived from either 
aliphatic amino acids (tricarboxylic acid cycle) or aromatic acids (shikimic acid 
pathway) (Figure 1) 11.  
 
Figure 1. Overview of the biosynthesis of plant secondary metabolites. The biosynthesis starts with the 
primary carbon metabolism, which involves important routes, such as the shikimic acid, malonic acid, 
mevalonic acid, and MEP pathways. The major classes of plant secondary metabolites are formed via 
the latter pathways (Chaturvedi 2012) 155.  
 
One branch of plant secondary metabolism leads to acylphloroglucinols and 
xanthones, which exhibit various pharmacologically interesting effects and applications 
and are substituted by C5 – C20 isoprene units 12. The isoprenoid substitution of the 
aromatic ring system increases the lipophilicity, thereby increasing the penetration 
tendency of the molecules through biological membranes 13. The mentioned plant 
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secondary metabolites are discovered widely distributed throughout the plant kingdom 
including Guttiferae (Clusiaceae), Leguminosae (Fabaceae), Cannabaceae, and 
Hypericaceae 13.   
A broad range of biological activities has been reported for (poly)prenylated 
(poly)phenols, e.g., anti-tumor, anti-bacterial, anti-viral, anti-oxidant, anti-tyrosinase, 
and estrogenic properties as well as sulfotransferases, nitric oxide, and phospholipase 
inhibitory activities14. The isolation of plant constituents is still very challenging, and the 
product yield obtained from the native production system is commonly low. Natural 
upscaling of plant systems requires large areas and long developing phases (up to one 
year). Furthermore, the reproducible production of the required product is expected to 
be environmentally dependent.  
The transfer of plant biosynthetic pathways into heterologous expression systems is 
very promising for future production processes of plant secondary metabolites. 
Metabolic engineering of the target host can overcome the upscaling challenges using 
plant systems to enable the recombinant production of plant constituents. Yeasts have 
been already genetically modified for the production of plant secondary metabolites, 
such as terpenoid taxadiene as a precursor molecule for the production of taxol 15; 
fragrances and flavors like vanillin 16,17; artemisinic acid as the precursor of the 
antimalarial artemisinin, 18; the polyphenolic heart-protective compound resveratrol 
19,20; carotenoids as vitamin A precursors with coloring and antioxidant properties 21; 
sulfur-rich amino acid-derived indolylglucosinolate as potential anti-cancer agent 10; 
the anti-inflammatory, antiviral, and antitumoral compound naringenine 22, as well as 
long-chain fatty acids utilized as high value compounds, e.g. lubricants, detergents, 
and polymers 23.  
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1.3. Hypericum perforatum, the medicinal plant 
The genus Hypericum belongs to the family of the Hypericaceae, which comprises 496 
species including trees, shrubs, and herbs 24,25. The most famous species known is 
the herb Hypericum perforatum (H. perforatum), also known as St. John´s wort. The 
latter name was given due to traditional reasons because it is flowering and harvested 
on the St John´s Day (24th of June, Figure 4). H. perforatum is one of the best 
investigated medicinal plants worldwide. It can be found all over the world, but it is 
majorily originated in parts of Europe and Asia. The typical herb size ranges from 15 
to 100 cm, having an erected stem that branches in the upper part. The leaves are 
oblong in shape, yellow-green in color, and 1–2 cm long. The leaves look like 
“perforated” due to the transparent translucent glands containing essential oil, giving 
the plant its Latin species name. The flowers are colored in bright yellow and about 2-
3 cm in diameter 26.  
In 2014, the plant was selected medicinal plant of the year due to its traditional and 
topically diverse medical applications 156. Since hundreds of years, it is used in the 
form of tinctures and oils for either oral or external admission. Medical applications 
include the treatment of skin injuries, sunburns, cramps, and diarrhea. Recent research 
also identified effects such as antimicrobial, antioxidant, photosensitization, anti-
inflammatory and anti-cancer activities 27. The broad range of applications is due to the 
synergistic effects of the wide variety of constituents within the plant 28. The most 
common medical application is the treatment of patients suffering from mild to 
moderate depression 29.  
 
 
Figure 2. The medicinal plant Hypericum perforatum. (A) plant, (B): open flower, (C): leave. 
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1.4. Hypericum perforatum, the constituents 
H. perforatum contains a diverse and complex mixture of pharmacologically active 
secondary metabolites such as phenylpropanes, flavonoids, biflavones, tannins, 
proanthocyanidins, naphthodianthrones, essential oil, amino acids, xanthones and, 
phloroglucinol derivatives 27,28,30,31. 
The essential oil consists mainly of monoterpenes and sesquiterpenes. Also, the 
presence of long-chain alcohols like alkanes and alkanols is known, which are mainly 
found within the translucent glands of the leaves. The sedative transmitter substance 
γ-aminobutyric acid has been identified at low concentrations. However, the overall 
concentration of this constituent is too low to have a significant impact as 
antidepressant 32.   
Phenylpropanes have been shown to have weak spasmolytic and antimicrobial 
activities. Typical constituents found are chlorogenic, caffeic, and p-coumaric acids in 
low concentrations 31,33.   
Flavonol glycosides are one of the major constituents ranging from 2-4% in H. 
perforatum. They were found to have spasmolytic and antidepressant activities (in vitro 
MAO-inhibiting properties). Typical compounds are quercetin (small amounts) besides 
rutin, quercitrin, hyperoside, and isoquercitrin 31,32.  
Naphthodianthrones such as protohypericin and protopseudohypericin, which are 
converted to hypericin, pseudohypericin and cyclopseudohypericin upon exposure to 
light, are also present in H. perforatum. Pharmaceutical effects like inhibition of the 
MAO enzyme (antidepressant) and antiretroviral activity were discovered. The 
compounds have an intense red color, phototoxic properties and are mainly formed in 
sepals, petals, and stamens within the plant 31,32.   
Xanthones were identified to show strong inhibition of the MAO enzyme, but the 
concentration in H. perforatum is too low to have antidepressant activity. Besides this 
antidepressant activity, also effects against Alzheimer have been reported 34.  
Xanthone derivatives can be found in trace concentrations in all parts of the plant 
including root, stem, and flower 31,32. 
Phloroglucinol derivatives such as hyperforin and adhyperforin are very lipophilic 
structures, mainly found in the reproductive parts of the plant such as the flowers, buds, 
and leaves. Adhyperforin increases from about 0.2 % in the flower to about 1.8 % in 
the ripe fruits and makes up 1/10 compared to the hyperforin content. During flower 
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development, the hyperforin content increases from 2.5 % (first bud phase) to 6.6 % 
(flower opening phase). The highest hyperforin concentration can be found in the fruits, 
reaching up to 8.5 % 31,35. The hyperforins are the best investigated and major 
constituents responsible for the pharmaceutical activity against depression 24,25,30,36.  
 
 
1.5. Pharmacological application of hyperforin  
The most common pharmacological use of hyperforin is the treatment of mild to 
moderate depression. Roughly, about 350 million people worldwide and about 4 million 
in Germany are suffering from depression 157. Depression is a mental disorder leading 
to e.g. loss of interest, low energy, erectile dysfunction and even suicide due to the low 
mood. The emotional disorder typically stays for weeks up to several years. The major 
causes are believed to be genetically innate, environmental, and/or psychological 
factors 37. Depression can be treated by psychotherapy, electroconvulsive therapy or 
by pharmaceutical medication. Besides psychotherapy, synthetic pharmaceuticals 
represent the most common way to treat depression. The major target is to increase 
the synaptic neurotransmitter concentration by blocking the transporter and therefore 
preventing the reuptake. The three major classes of synthetic antidepressants are 
serotonin selective reuptake inhibitors (SSRIs), tricyclic antidepressants (TCAs) and 
monoamine oxidase inhibitors (MAOIs) 37. TCAs inhibit simultaneously the reuptake of 
serotonin, (nor)adrenalin and dopamine by blocking the relevant transporters. 
Selective reuptake inhibitors are specific for one neurotransmitter such as serotonin 
and dopamine. MAO inhibitors reduce the activity of the MAO enzyme, which is 
responsible for the degradation of intraneuronal neurotransmitters, leading to an 
increase of the synaptic neurotransmitter concentration 37. Typical side effects caused 
by synthetic pharmaceuticals vary individually and may involve dizziness, blood 
pressure fluctuations, stomach discomfort, digestive disorders, fatigue, sleep disorder, 
lack of appetite and sexual dysfunction 38. Undesired effects are less with 
phytopharmaceuticals used for treatment of mild to moderate depression, e.g. extracts 
from the medicinal plant St. John´s wort containing hyperforin, which has been 
identified as a major active constituent. 24,39. 
The mode of action of hyperforin is not completely understood yet. Until today, there 
are two major principles described; the more recent one describes the discovery of 
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hyperforin acting as a protonophore. The second principle describes the interaction of 
hyperforin with the neurotransmitter receptor TRPC6, thereby increasing the synaptic 
neurotransmitter concentration 36,39,40. 
 
 
1.6. The hyperforin biosynthesis, still a secret 
Hyperforin is a lipophilic bicyclic polyprenylated acylphloroglucinol (PPAP) derivative 
consisting of a mixture of interconverting tautomers leading to poor resolutions of 1H 
and 13C NMR measurements 24,30,31,41,42. Its unstability against light, oxygen, 
temperature and non-polar solvent is due to the enolized β-dicarbonyl system  24,30,31,41. 
Stabilization was achieved using the dicyclohexylammonium salt 24. Due to the highly 
complex structure of hyperforin, the total synthesis could be achieved by chemical 
reactions ranging from 10 to 35 steps. However, the chemical synthesis approaches 
are very laborious, ending in low yield insufficient for further medical research 43–46.  
The biosynthetic pathway is not yet completely understood. As proposed by Beerhues 
(2006), the biosynthesis of hyperforin (Figure. 3) starts with the formation of the core 
skeleton, phlorisobutyrophenone (PIBP), by the condensation of 3 molecules of 
malonyl-CoA and one molecule of isobutyryl-CoA. This reaction is catalyzed by a type 
III polyketide synthase (PKS), referred to as phlorisobutyrophenone synthase 47,48. The 
subsequent decoration of PIBP occurs with residues that are derived from the non-
mevalonate (MEP) pathway. These side chains include dimethylallyl pyrophosphate 
(DMAPP)-derived prenyl groups and geranyl pyrophosphate (GPP)-derived geranyl 
groups, which are attached by membrane-bound aromatic prenyltransferase (PT) 
enzymes, giving the hydrophobic properties 24,30,49. 
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Figure. 3 Proposed hyperforin biosynthesis. Modified from Beerhues (2006) 24. 
 
 
1.7. Acyl-CoA ligases, the starting point 
Acyl-CoA ligases are widely distributed throughout the plant kingdom. They are 
involved in the biosynthesis of many plant secondary metabolites such as bitter acids,  
xanthones, flavonoids, and guaiacyl-lignin 48,50,51. In the hyperforin biosynthetic 
pathway, these enzymes catalyze the enzymatic conversion of carboxylic acid 
derivatives including isobutyric, 2-methylbutyric, and isovaleric acids to their CoA 
esters (Figure 4). The latter substrates are derived from the degradation of the 
branched-chain alpha acids, including valine to form isobutyryl-CoA, leucine to form 
isovaleryl-CoA and isoleucine and/or threonine to form 2-methylbutyrl-CoA 48. 
Isovaleryl-CoA is involved in the biosynthesis of phlorisovalerophenone (PIVP), the 
core skeleton of β-bitter acid derived from hop 48,52,53. In contrast, isobutyryl-CoA and 
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2-methylbutyryl-CoA are involved in the biosynthesis of hyperforin and adhyperforin, 
respectively 24,54. 
The reaction mechanism of acyl-CoA ligases is catalyzed in two steps (Figure 4). The 
first step is the adenylation of the carboxylic acid group of isobutyric acid to form an 
acyl-AMP intermediate. The second step involves the displacement of AMP with CoA 
to form the corresponding isobutyryl-CoA product (Figure 4).  
 
 
Figure 4. Formation of isobutyryl-CoA. Adenylation of isobutyric acid to form an acyl-AMP intermediate, 
followed by displacement of AMP with CoA to form isobutyryl-CoA. 
 
 
1.8. Polyketide synthases, with tremendous catalytic features   
Polyketides are a very large group of natural products, which can be found in all 
kingdoms of life including plants, bacteria, fungi and other eukaryotic organisms 55–57. 
They show a large spectrum of pharmacological activities such as antibiotic, 
anticancer, and immunosuppressive activities. Within plant species, they are produced 
for UV protection, disease resistance, and against microbial invasion and insects 57–59.  
Polyketide synthases can be divided into three different types. Type I polyketide 
synthases (modular type) are large and highly modular proteins with several domains. 
These domains contain a ketosynthase domain, acyl carrier protein (ACP) domain, and 
an acyltransferase domain. Ketosynthases belong to the family of thiolases, converting 
acetyl-CoA to acetoacetyl-CoA in the mevalonate pathway. This is carried out by a 
Claisen condensation following a carbon-carbon bond formation while releasing the 
thiol-CoA group. The acyl carrier protein binds the thioester group of the CoA ester 60. 
Type II polyketide synthases (subunit type) are aggregates of the heterodimeric 
ketosynthase domain and ACP 61.  
Type III polyketide synthases are homodimers, only consisting of a single ketosynthase 
domain with a small size of about 40 – 45 kDa (Structure/Function) 62.  
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This single ketosynthase domain performs all reactions alone as found in type I and 
type II PKSs 63. The reaction itself is divided into two reactions: the first step is the 
condensation of the starter substrate with several extender substrates. The extender 
substrate is typically malonyl-CoA while the starter substrates are variable. The 
variable starter substrates are divided into three different types based on the acyl-CoA 
nature: 1) aromatic acyl-CoA such as p-coumaroyl-CoA, benzoyl-CoA, cinnamoyl-
CoA, 2) short-chain acyl-CoA, e.g. isovaleryl-CoA, isobutyryl-CoA, and hexanoyl-CoA, 
and 3) long chain-CoA such as cerotyl-CoA. A linear polyketide intermediate is formed 
which is finally cyclized to form the aromatic structure (Figure 5). 
 
Figure 5. Biosynthesis of phlorisobutyrophenone (PIBP). Condensation of three molecules of malonyl-
CoA with one molecule of isobutyryl-CoA to form PIBP.   
 
In general, PKSs have a broad substrate specificity for the starter molecules. 
Therefore, plant PKSs are responsible for the biosynthesis of a wide variety of plant 
secondary metabolite backbones. The first type found was a chalcone synthase, which 
is involved in the biosynthesis of naringenin chalcone in parsley. Also, the biosynthesis 
of stilbenes, phloroglucinols, resorcinols, benzophenones, pyrones, and even more 
has been reported 59,62–70. Many PKS products serve as core skeletons for the 
formation of further plant constituents. Benzophenone derivatives, for example, are 
further converted to xanthone derivatives catalyzed by P450 monooxygenase 71. Also, 
high molecular weight structures such as oktaketides (hypericins), which are present 
in Hypericum species and provide the red pigment, are formed by PKS 72.   
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1.9. Prenyltransferases, the key enzymes 
Prenyltransferases (PTs) are involved in the biosynthesis of a vast number of primary 
and secondary metabolites. They are divided into two groups classified by their natural 
function and named as prenyl diphosphate synthases and aromatic 
prenyltransferases. Both belong to the class of enzymes that transfer (homo)allylic 
prenyl groups, e.g. DMAPP-derived C5, to different acceptor molecules 12,73,74.   
Prenyl diphosphate synthases are involved in the biosynthesis of different terpenoids 
and in the posttranslational modification of peptides, proteins, and tRNA. The terpenoid 
biosynthesis starts with the condensation of DMAPP (C5)  as prenyl acceptor and IPP 
(C5) as donor molecule 75. These precursor molecules are members of a large 
molecule family, which plays a crucial role in the biosynthesis of many secondary 
metabolites such as pigments and hormones. Protein prenyltransferases transfer 
either FPP (C15) or GGPP (C20) to peptides or proteins serving as acceptor molecules 
74. The latter posttranslational modifications are responsible for correct protein 
localization and activity. Additionally, tRNA is prenylated, which is required for 
translational regulation 75. Prenyl diphosphate synthases can be found in all living 
organisms and are known to be soluble proteins, with some being divalent cation-
dependent 12,74,75.       
Many aromatic prenyltransferase (PT) enzymes have been isolated and biochemically 
characterized throughout the living kingdoms of fungi, bacteria and plants 12,74,75. PTs 
isolated from fungi and bacteria occur as soluble proteins, whereas plant-derived PTs 
are membrane-bound enzymes 75.  
Plant-derived aromatic PTs transfer prenyl moieties derived from the MEP pathway 
(C5, isopentenyl; C10, geranyl; C15, farnesyl; C20, geranylgeranyl) onto its acceptor, 
while forming C-C, C-N or C-O bonds (Figure 6) 74,76.  
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Figure 6. Combination of the shikimate/malonate and isoprenoid pathways to form aromatic PT 
substrates. The isoprenoid moieties are formed in the cytosolic mevalonate (MVA) pathway and the 
plastid-localized methyl erythritol phosphate (MEP) pathway. Modified from Yazaki 2009 12.  
 
The acceptors are very diverse and include phenols, flavonoids, phenolic acids, 
coumarins, naphthalenes 25. The most abundant compounds carry isopentenyl or 
geranyl side chains rather than farnesyl or geranylgeranyl side chains 77.  
Plant-derived aromatic PT enzymes are involved in the biosynthesis of secondary 
metabolites and are mainly located in the membrane of plastids. They also contain 
aspartate-rich motifs, e.g., NDxxDxxxD, and are strongly dependent on divalent 
cations 12,25,74,75. Recent studies have shown that plant-derived membrane-bound 
aromatic prenyltransferases are involved in the biosynthesis of a number of different 
biosynthesis pathways and in the prenylation of various aromatic compounds such as 
xanthones, benzoic acid derivatives, (iso)flavonoids, coumarins and phloroglucinol 
derivatives 34,77–95.  
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Figure 7: Reaction of aromatic prenyltransferases. Membrane-bound aromatic PTs have conserved 
aspartate-rich motifs located in the cytosolic loops (L1 and L3) and an N-terminal transit peptide (TP). 
Acceptor molecules such as phloroglucinol-derivatives are prenylated or geranylated to form the 
corresponding derivatives. R = H or OH, R´ = (CH3)2; CH2 – CH – (CH3)2; (CH3)2 – CH3; C6H5. Modified 
from Gaid et. al. 2017. 
 
Prenylated compounds demonstrate a large variety of biological activities and are 
therefore promising high-potential candidates for future drug development 77. Due to 
their lipophilic character, the bio-barrier penetration of the molecules is supported, 
which facilitates the pharmacological effects 96. Thus, there is a growing interest to 
provide further research for the production of polyprenylated aromatic compounds as 
perspective candidates for future medical applications. 
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1.10. Objectives 
Hyperforin is identified as a major constituent of St. John's wort, which is responsible 
for many pharmacologically interesting effects, such as antidepressant, antibacterial, 
anti-inflammatory, and antitumoral properties. Due to the versatile applications of 
hyperforin-rich extract, hyperforin is considered as a promising herbal metabolite. 
However, the extraction of hyperforin from the plant is difficult. The instability to normal 
environmental conditions makes the standardisation of the extract challenging. In 
addition, the hyperforin concentrations vary in St. John's herb from plant to plant but 
also between various plant organs. All the aforementioned critical parameters increase 
the market price of hyperforin to currently around 200 € per mg. The chemical synthesis 
of hyperforin has already been achieved by several approaches. Nevertheless, at least 
10 steps are currently required for the total chemical synthesis.  
Due to the low yields achieved by chemical synthesis, a commercial large-scale 
synthesis is not economic. One possibility to obtain cost-effective yields would be the 
heterologous production in fast-growing organisms, such as tobacco and yeast. 
However, the full biosynthetic pathway is not yet fully understood, making the complete 
heterologous expression impossible. The postulated hyperforin biosynthesis is based 
on at least six enzymes. Due to this high number of enzymes to be expressed, a 
genome integration protocol for the production organism is required. 
The aims of the present work are as follows. 
1. Functional expression in yeast of previously isolated acyl-CoA ligase and 
polyketide synthase. 
2. Functional expression and full characterization of previously isolated 
prenyltransferase genes. 
3. Establishment of a yeast genome integration protocol for multiple gene 
integrations.
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2. Materials and Methods 
 
2.1. Chemicals 
Unless stated otherwise, all chemicals used were of analytical grade and purchased 
from Carl Roth GmbH (Karlsruhe, Germany), Sigma Aldrich (Steinheim, Germany), 
Fluka (Neu-Ulm, Germany), AppliChem (Darmstadt, Germany), Merck (Darmstadt, 
Germany), Thermo Fischer Scientific (Darmstadt, Germany), Becton Dickinson 
(Heidelberg, Germany), Bio-Rad (München, Germany), J.T. Baker (München, 
Germany), Nippon Genetics (Düren, Germany), Cayman Chemical (Michigan, USA), 
VWR (Darmstadt, Germany) and Qiagen (Hilden, Germany). The following chemicals 
used in this study were chemically synthesized: DMAPP, PIBP, PIVP, 2-MBP, 3-g-
PIBP, 3-g-PIVP, 3-g-PAP, 3-g-PBP, and 3-g-2-MBP.   
 
 
2.2. Enzymes and PCR components 
Phusion Hot Start II DNA Polymerase (2 U/µL), Phusion U Hot Start DNA Polymerase, 
dNTPs, Restriction enzymes (10 U/µL), Alkaline Phosphatase (1 U/µL), and T4 DNA 
Ligase (5 Weiss U/µL) were purchased from Thermo Fischer Scientific (Darmstadt, 
Germany). peqGOLD Taq DNA Polymerases (5 U/µL) was obtained from VWR 
(Peqlab, Darmstadt, Germany).  Oligonucleotides used for standard PCRs and USER-
cloning were synthesized either at Eurofins MWG Operon (Ebersberg, Germany) or 
Microsynth (Balgach, Switzerland) and produced at high purity salt-free (HPSF) grade. 
 
 
2.3. Kits 
The following kits were used for the molecular biological and microbiological works.   
   
Table 1. Kits 
Kit Application Manufacturer  
InnuPREP DOUBLEpure 
PCR product  
purification 
Analytic Jena 
S.c. EasyComp™ Preparation of competent Thermo Fischer Scientific 
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Transformation Kit yeast cells and 
transformation 
Yeast DNA Extraction Kit  Extraction of genomic DNA Thermo Fischer Scientific  
 
 
2.4. Equipment, Software 
The following equipment and software were used during this study.   
 
Table 2. Equipment 
Device Model Manufacturer 
Autoclave Vx-120 Systec GmbH 
Clean bench LaminAir HLB 2472 Heraeus 
DASGIP Bioreactor  Bioblock (CWD 4) Eppendorf  
Electrophoresis chamber   BioRad 
Filters 0.2 µm Acrodisc syringe filter PALL Life sciences 
Glas beads 425-600 µm Sigma-Aldrich 
Heating block DriBlock DB 3D Techne 
HPLC (Agilent 
Technologies) 
1260 Infinity Agilent Technologies 
HPLC (VWR-Hitachi) 
Elite LaChrom series, 
Diode Array Detector (L-
2455), 
VWR-Hitachi 
Imager Infinity 3026 Peqlab 
Incubator HT Minitron / HT Multitron Infors HT 
LED-Transilluminator  Nippon Genetics 
Mass spectrometer 
3200 Q TRAP LC/MS/MS 
System 
Applied Biosystems Sciex 
MilliQ water Purification 
System 
Arium 611 Satorius 
NanoDrop SimpliNano GE Healthcare 
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PCR Cycler 
T Professional Basic 
Gradient 
Biometra 
PCR cycler T Professional Biometra 
pH-Meter Digital pH Meter 325 WTW 
Power supply  
(agarose gel 
electrophoresis) 
power-pack 300 BioRad 
Scale LA230S Sartorius 
Shaker Minitron Infors HT 
Spectrophotometer Ultrospec 1000 Pharmacia Biotech 
Steril Werkbank HLB 2472 Heraeus 
Sterile filter 
Millex®-Filtereinheiten 
(0.22 µm, PE5 Membran) 
Roth 
Ultrasonic Cell-Disrupter Sonifier 250 Branson (G. Heinemann) 
Vortexer Vortex Genie 2 Scientific Industries 
Water bath MW4 Julabo 
Centrifuge(s) 
Biofuge pico Heraeus 
Universal 32R Hettich Zentrifugen 
Avanti®-J-E Centrifuge Beckman Coulter 
Biofuge 13 Heraeus Sepatech 
Sigma 1-15K Sigma 
Universal 32R Hettich 
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Table 3. Software 
Name  Version  Manufacturer 
Agilent ChemStation for 
LC 3D systems  
Rev. B.04.03(16) Agilent Technologies, Inc.  
ChemDraw Professional  15.1.0.144 
PerkinElmer Informatics, 
Inc.  
Hyper32 1.0.0  
John S. Easterby 
http://hyper32.software.inf
ormer.com/Sicherer-
download/ 
LSM Image Browser  3.5.0.223 Carl Zeiss GmbH 
OriginPro Version 2016G OriginLab Corporation  
 
 
2.5. Organisms 
Molecular cloning and plasmid amplification were performed with the E. coli DH5α 
strain. Recombinant protein expression was carried out using the S. cerevisiae INVSc1 
strain. The genotype of each strain is shown in Table 4.   
 
Table 4. Organisms 
Organisms Application Genotype 
E. coli DH5α Plasmid amplification F‘φ80δlacZ9M15endA1hsd
R17(rk-mk+)supE44thi-
1λ-gyrA96relA19(lacZYA-
argFV169) deoR 
S. cerevisiae INVSc1 Rec. protein 
expression  
MATa his3D1 leu2 trp1-289 
ura3-52 MAT His3D1 leu2 
trp1-289 ura3-52 
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2.6. Cultivation media 
The LB-medium (Table 5) was used for the cultivation of the E. coli DH5α strain. S. 
cerevisiae pre-cultures were prepared in SGI-medium and the main-cultures in YPSE-
medium. 
 
Table 5. Cultivation media 
Medium Components Concentration 
LB-medium* 
Casein peptone 10 g/L 
NaCl 10 g/L 
Yeast extract 5 g/L 
SGI-medium* 
Bacto Casamino Acids 1 g/L 
Yeast nitrogen base 
(without amino acids) 
6.7 g/L 
Glucose 20 g/L 
YPSE-medium 
Yeast extract 10 g/L 
Bacto-peptone 10 g/L 
Sucrose 5 g/L 
Ethanol 30 mL/L 
* gar (15 g/L) was added for obtaining solid medium  
 
 
2.7. Molecular Biological Methods 
 
2.7.1. Oligonucleotides 
PCR and sequencing primers were designed by the following primer criteria for 
successful PCR amplification: GC Range: 50 to 60 %, Tm Range: 55 to 70 °C, GC 
clamp at the 3´end, avoiding primer dimers and hairpins.      
Criteria for sequencing primers: same as for PCR primers, except that Tm was chosen 
to have about 55 °C.  Sequencing data were analyzed by the Clone Manager software. 
The primer tables can be found in the appendix 6.4. Oligonucleotides, page 138. 
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2.7.2. Polymerase chain reaction (PCR) 
Polymerase chain reaction (PCR) was carried out for all in vitro DNA amplifications 
using either Phusion Hot Start II DNA Polymerase or peqGOLD Taq DNA 
Polymerases. The Phusion Hot Start II DNA Polymerase was exclusively used for the 
amplification of amplicons required for recombinant protein expression in S. cerevisiae. 
This enzyme provides no or very low mutational errors (4.4 x 10-7 single nucleotide 
polymorphisms = SNPs) due to its 3´→ 5´ exonuclease activity (proof reading activity). 
PeqGOLD Taq DNA Polymerases was mainly used (if not stated otherwise) for colony 
PCR (Table 21, page 32). The standard reaction volume was 25 µL and the 
composition prepared as described in Table 6.  
 
Table 6. PCR setup using Phusion Hot Start II High-Fidelity DNA Polymerase 
Component Quantity 
5x Phusion HF-buffer 5.0 µL 
dNTPs (2 mM) 2.5 µL 
Template DNA 0.1-10 ng 
Forward Primer (5 µM) 2.5 µL 
Reverse Primer (5 µM) 2.5 µL 
Phusion polymerase 0.25 µL 
ddH2O ad. 25 µL 
 
A typical PCR program used for the amplification of the GOI is shown in Table 7. The 
annealing temperature depends on the primer pairs and was adjusted according to the 
Tm calculated by Clone manager. The time of DNA amplification depends on the 
polymerase used in the PCR reaction. For the Phusion Hot Start II High-Fidelity 
polymerase 15-30 s/kb (Table 7) and for the peqGOLD Taq DNA Polymerases 60 s/kb 
were used (Table 22, page 33).   
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Table 7. Thermocycler program for DNA amplification using Phusion Hot Start II 
DNA Polymerase 
Step Temperature (°C) Time (min:sec) 
1. Initial Denaturation 98 00:30 
2. Denaturation 98 00:10 
3. Annealing 55 - 65 00:30 
4. Extension* 72 00:15 – 00:30 per kb 
5. Final Extension 72 04:00 
6. Hold 4 - 
* 25 - 30 cycles from step 1 - 4.  
 
 
2.7.3. Restriction digestion 
Restriction enzymes were mainly used for: 
1. Template degradation after PCR amplification of target genes using DpnI.    
2. Generation of compatible ends of plasmid DNA and PCR fragments for molecular 
cloning.   
 
2.7.3.1. Template degradation after PCR amplification of target genes using 
DpnI 
Plasmid DNA isolated from E. coli DH5α, which was used as a template in the PCR 
reaction, is methylated and can, therefore, be digested with the restriction enzyme 
DpnI. The recognition sequence is GATC with the base adenine being methylated. The 
following procedure reduces the background of colonies containing only template DNA. 
In the following Table 8 a standard DpnI digestion is shown, taking the PCR reaction 
mixture from Table 6, page 20.        
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Table 8. Components of the DpnI restriction digestion 
Component Quantity 
PCR Reaction Mixture 25 µL 
DpnI Enzyme 1.0 µL 
10x Tango Buffer 5.0 µL 
ddH2O ad. 19.0 µL 
Incubation time and temp. 1 – 2 h at 37 °C 
 
After the DpnI digestion, the innuPREP DOUBLEpure kit was used for the purification 
of the PCR DNA. The purification was done according to the manual, except that the 
elution was done twice with 20 µL of elution buffer. 
 
 
2.7.3.2. Generation of compatible ends of plasmid DNA and PCR fragments for 
molecular cloning 
For cloning a standard gene into an e.g. pESC_URA vector, the sticky end cloning 
method was mainly used. To check whether a double digest can be performed, the 
double digest finder (press: Link) from Thermo Fischer Scientific was used. In  Table 
9 a double digest is shown as an example for plasmid DNA and in Table 10, page 23 
for the GOI.  
Table 9. Restriction digestion of the plasmid DNA 
Component Quantity 
Plasmid DNA 2 – 10 µg 
10x Enzyme Buffer 5.0 µL 
Restriction Enzyme 1 1.0 µL 
Restriction Enzyme 2 1.0 µL 
Alkaline Phosphatase (AP) 1.0 µL 
ddH2O ad. 50 µL 
Incubation time and temp. 1 – 2 h at 37 °C 
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Table 10. Restriction digestion of the PCR fragment 
Component Quantity 
PCR fragment (µg) variable 
10x Enzyme Buffer 5.0 µL 
Restriction Enzyme 1 1.0 µL 
Restriction Enzyme 2 1.0 µL 
ddH2O ad. 50 µL 
Incubation time and temp. 1 – 2 h at 37 °C 
 
 
2.7.4. Ligation 
For the ligation of linearized plasmid DNA with previously amplified and digested PCR 
fragments, the T4 DNA Ligase was used. A typical ligation reaction composition can 
be reviewed in Table 11. Depending on the vector and insert size, the molar ratio was 
chosen between 1:1 to 1:5.  
The amount of insert used was calculated by the following formula: 
 
 𝐴𝑚𝑜𝑢𝑛𝑡 𝑖𝑛𝑠𝑒𝑟𝑡 [𝑛𝑔] =  
𝐴𝑚𝑜𝑢𝑛𝑡 𝑉𝑒𝑐𝑡𝑜𝑟  [𝑛𝑔]∗𝑆𝑖𝑧𝑒 𝐼𝑛𝑠𝑒𝑟𝑡 [𝑘𝑏] 
𝑆𝑖𝑧𝑒 𝑉𝑒𝑐𝑡𝑜𝑟 [𝑘𝑏]
∗ 𝑀𝑜𝑙𝑎𝑟 𝑟𝑎𝑡𝑖𝑜 𝐼𝑛𝑠𝑒𝑟𝑡 
𝑉𝑒𝑐𝑡𝑜𝑟
   
Figure 8. Formula to calculate vector/insert ratio 
 
Table 11. Composition of a typical ligation reaction using T4 DNA Ligase 
Component Quantity 
T4 DNA Ligase 1 µL 
Vector (100 ng/µL) 1 µL 
Insert a molar ratio to vector (1:1 to 1:5) 
10X T4 DNA Ligase Buffer 2 µL 
ddH2O ad. 20 µL 
Incubation time and temp.  overnight at 16 °C 
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In case no proper restriction enzymes were found to perform the sticky end cloning 
method, the blunt cloning method was chosen. A standard blunt end cloning 
composition is shown in the following Table 12.  
 
Table 12. Composition of a typical blunt end ligation reaction using T4 DNA 
Ligase 
Component Quantity 
Plasmid DNA 200 ng 
PCR fragment 180 ng 
10x T4 Ligase Buffer 2.0 µL 
T4 Ligase Enzyme 1.0 µL 
SmaI/SrfI Enzyme 1.0 µL 
ddH2O ad. 20 µL 
Incubation time and temp. overnight at 16 °C 
 
 
2.7.5. Agarose gel electrophoresis 
Agarose gel electrophoresis was used as an analytical method to separate DNA 
fragments according to their differences in size. All agarose gels were prepared by 
dissolving 1 % (w/v) agarose (peqGold Universal Agarose, Peqlab, Germany) in 1x 
TAE-buffer (Table 13, page 25). For DNA staining, 5 µL Midori Green (Nippon Genetics 
Europe GmbH, Düren, Germany) per 100 mL agarose was added after agarose was 
dissolved. A proper amount of DNA samples was mixed with 6x loading dye (Figure 9, 
page 25) and run between 90 to 120 V until an appropriate separation was obtained. 
GeneRuler 1 kb DNA Ladder (100 to 10,000 bp) (Figure 9, page 25) was used as a 
marker to estimate sample DNA size. DNA visualization was achieved using a UV 
transilluminator, which illuminates fluorophores at a wavelength of 312 nm (UV-B).  
If necessary, linearized plasmid DNA or PCR fragments were extracted from the 
agarose gel by cutting out the required band. To prevent mutations within the DNA 
strands caused by the UV light, a LED transilluminator (Nippon genetics) was used. 
Finally, the DNA was purified using the innuPREP DOUBLEpure kit. The procedure 
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was followed according to the manual, except that the elution was done twice with 20 
µL of elution buffer. 
 
Figure 9: GeneRuler 1 kb DNA ladder (Thermo Fischer Scientific). 
 
Table 13. Buffer for agarose gel electrophoresis and Loading Dye 
Buffer Composition Quantity 
50 x TAE 
Tris-HCl 2.0 M 
Acetic Acid 1.0 M 
EDTA 0.05 M 
pH 8.0  
6x Loading Dye 
Tris-HCl pH 7.5 10 mM 
EDTA 60 mM 
Glycerol 60 % (v/v) 
Bromophenol Blue 0.03 % (w/v) 
Xylene Cyanol FF 0.03 % (w/v) 
 
 
2.7.6. Plasmid isolation from E. coli 
For the propagation of plasmid DNA, the corresponding plasmids were first 
transformed into E. coli DH5α (Table 4, page 18), which were then cultivated on LB-
agar plates containing the appropriate antibiotic. One single colony was picked, 
Material and Methods 
 
26 
 
transferred into 5 mL LB-medium (Table 5, page 19) and grown overnight at 37 °C and 
220 rpm. Thereafter, 1.5 mL cell culture was centrifuged for 20 sec. The pellet was 
resuspended in 150 µL buffer 1 (Table 14) and let sit for 5 min at room temperature. 
150 µL buffer 2 (Table 14) was added, mixed (invert) and placed on ice for 5 min. 
Afterwards, 150 µL buffer 3 (Table 14) was added, mixed and placed on ice for another 
5 min. Few drops of chloroform were added, mixed and the cell solution centrifuged for 
additional 5 min (13.000 rpm). An aliquot of 0.4 ml of the supernatant was transferred 
to a new 1.5 mL tube containing 0.8 mL 100 % isopropanol and vortexed vigorously. 
Afterwards, the tube was centrifuged for 10 min., the supernatant discarded, the pellet 
washed with 1 mL 70% ethanol and dried at 37 °C. The DNA pellet was then 
resuspended in 50 µL H2O and the DNA concentration quantified using a NanoDrop 
spectrophotometer prior to storage at -20 °C.  The plasmids were prepared following 
the company’s instructions and sequenced at either MWG (Ebersberg, Germany), 
Source BioScience (Berlin, Germany) or GATC Biotech (Konstanz, Germany).      
 
Table 14. Composition of plasmid isolation buffers by alkaline lysis and ethanol 
precipitation 
Buffer Component Concentration 
Buffer 1 pH 8.0 
(Resuspension Buffer) 
Tris-HCl 50 mM 
EDTA 10 mM 
RNase A (10 mg/mL) 100 µg/mL 
Buffer 2 
(Lysis Buffer) 
SDS 1% w/v 
NaOH 0.2 M 
Buffer 3 pH 5.5 
(Neutralization Buffer) 
Potassium Acetate 3 M 
Glacial acetic acid is used 
for pH adjustment 
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2.7.7. Plasmid construction for genome integration of DNA fragments into S. 
cerevisiae using Easyclone 
The development of efficient production strains to produce chemicals and APIs 
requires efficient methods of genetic engineering. One major aspect is the stable 
integration of the required enzyme cascade into the genome. The plasmid-based 
expression is firstly limited to the number of genes, which can be functionally 
expressed, and secondly to the number of antibiotics which can be used for the 
selection of positive transformants. Detailed background explanation can be found in 
the discussion part of this thesis (section 4.5., page 90). A number of different cloning 
methods, e.g. Infusion cloning, Gateway cloning, Gibbson assembly, Ligase Cycling 
Reaction, and Golden Gate cloning have been developed during the last decades 23,97–
102. 
 For the stable integration of the enzymes used in this thesis, the EasyClone USER 
method for iterative chromosomal integration of multiple genes in S. cerevisiae was 
used (personal communication Dr. Irina Borodina from the University of Technical 
University of Denmark) 103.  
The principle behind this method will be described in more detail in this section. USER 
cloning is the abbreviation for uracil-specific excision reaction. The basic principle 
behind this cloning technique is to generate compatible overhangs of vector and GOI 
independent of any restriction enzyme. This enables to ligate every GOI with a vector 
without considering any misdigestion of the vector backbone or the target gene by 
using the restriction enzyme-based cloning techniques. This can be achieved by using 
the so-called “USER cassette” and USER primer. The USER cassette has to be 
available in the plasmid backbone of interest and the gene-specific primer, containing 
compatible ends of the vector and target gene created without commonly used 
restriction enzymes. The primers used for the amplification of the GOI contain one 
uracil base, which enables later the generation of the overhangs compatible with each 
other. For the amplification of the GOI, a special Phusion polymerase is required, which 
is called Phusion U polymerase. This Phusion polymerase is able to read over the 
uracil base, due to a mutation without losing the proofreading activity. With a “normal” 
Phusion polymerase, the amplification would not be possible, because the enzyme 
would stall (´fall down´) from the template. The obtained PCR product is treated with a 
uracil DNA glycosylase and DNA glycosylase-lyase Endo VIII. These enzymes remove 
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the two uracil bases and generate the 8nt long compatible ends of the PCR product 
and of the USER cassette of the plasmid backbone. The length of 8 nt enables a very 
efficient ligation reaction with the USER enzyme in the subsequent steps 103. In the 
following Figure 10, the detailed cloning procedure is shown.  
 
Figure 10. Overview of the gene cloning procedure into EasyClone vectors 103. 
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2.7.7.1. PCR amplification of integration parts for USER cloning 
The Phusion U DNA Polymerase was exclusively used for the amplification of 
fragments required for the genome integration and recombinant protein expression in 
S. cerevisiae. The standard reaction volume was 50 µL, which was prepared as 
described in Table 15. 
 
Table 15. PCR setup using Phusion U Polymerase for USER cloning 
     
 
Table 16. Thermocycler program using Phusion U polymerase for USER cloning 
Step Temperature (°C) Time (min:sec) 
1. Initial Denaturation 98 00:30 
2. Denaturation  98 00:10 
3. Annealing  55 - 65 00:30 
4. Extension* 72 00:15 – 00:30 /kb 
5. Final Extension 72 04:00 
6. Hold 4 - 
* 25 - 30 cycles from step 1 - 4.  
 
After the PCR reaction, the sample was treated in the same way as described in the 
section 2.7.3.1., page 21. 
Composition Quantity  
5x Phusion HF Buffer 10.0 µL  
dNTPs (2 mM) 5.0 µL 
pESC_URA_rv gene+USER 5.0 µL  
pESC_URA_fw gene+USER 5.0 µL  
Template  1 pg – 10 ng 
Phusion U Polymerase  0.5 µL 
ddH2O ad. 50 µL  
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2.7.7.2. Preparation of integration vector for USER cloning 
USER cloning vector backbones isolated from E. coli (DH5α), must be treated with two 
different enzymes to generate compatible overhangs, enabling the ligation with the 
PCR product. The treatment must be carried out in two subsequent steps due to the 
different incubation temperature and buffer requirements. In the following two tables 
(Table 17 and Table 18) the standard reaction conditions are shown.  
 
Table 17. Preparation of USER vector backbone step 1 
Component  Quantity 
10x Fast Digest Buffer  5.0 μL 
pCfB389  20 μg  
AsiSI  2.0 μL  
ddH2O ad. 50 μL 
Incubation time and temp.  4 h at 37 °C 
 
After AsiSI digestion, the innuPREP DOUBLEpure kit was used for the purification of 
the PCR DNA. The purification was done according to the manual, except that the 
elution was done twice with 20 µL elution buffer. 
After the AsiSI enzyme treatment, the purified DNA fragment was treated with Nb.BsmI 
enzyme (Table 18). 
 
Table 18. Preparation of USER vector backbone step 2 
Component  Quantity 
purified AsiSI treated DNA 40 μL (>1 µg) 
10x Buffer 3.1  5.0 μL  
Nb.BsmI  2.0 μL  
10x Buffer 3.1  5.0 μL  
ddH2O ad. 50 μl  
Incubation time and temp. 2 h at 65 °C 
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Following Nb.BsmI digestion, the innuPREP DOUBLEpure kit was used for the 
purification of the PCR DNA. The purification was done according to the manual, 
except that the elution was done twice with 20 µL elution buffer. 
 
2.7.7.3. USER reaction 
After the preparation of the USER vector and the amplification of the target gene, the 
ligation using the USER enzyme was performed. A molar ratio of vector:GOI = 1:3 was 
chosen. A typical ligation reaction composition can be reviewed in Table 19. 
 
Table 19. USER reaction 
Component  Quantity 
USER plasmid* x μL 
GOI* x μL  
USER Enzyme  1 μL  
Buffer 3.1  4 μL  
ddH2O ad. 50 μL  
1. Incubation time and temp. 15 min. at 37 °C 
2. Incubation time and temp. 15 min. at 25 °C 
*Plasmid:GOI ratio = 1:3 
 
After the USER reaction, the plasmid was directly transformed into E. coli DH5α 
(section 2.8.1.2., page 34), positive transformants tested by colony PCR (section 
2.7.8., page 32) and one positive plasmid isolated (section 2.7.6., page 25). For 
successful genome integration, the plasmid must be linearized which was achieved by 
NotI digestion as described in Table 20. 
 
Table 20. USER plasmid NotI digestion 
Component  Quantity 
Plasmid  100 µg 
10x Buffer O 1.0 μL  
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NotI  2.0 μL  
ddH2O ad. 10.0 μL  
Incubation time and temp. 4 h at 37 °C 
 
After NotI digestion, the GOI fragment was separated and isolated from the remaining 
plasmid backbone by agarose gel electrophoresis (section 2.7.5, page 24). The 
obtained eluent was concentrated up by lyophilization overnight. About 300 – 700 µg 
linearized genome integration fragment was finally transformed into S. cerevisiae 
(section 2.8.2.2., page 36) and the cells plated out on selection plates (depending on 
the USER backbone used). Successful DNA fragment integration was verified by yeast 
genomic DNA extraction (section 2.7.9., page 33) and the subsequent amplification of 
the target insert and/or promoter by PCR (section 2.7.2., page 32). 
 
 
2.7.8. Colony PCR of E. coli 
Verification of successful cloning, as described previously, was carried out by colony 
PCR. A single colony was picked from a LB-agar plate, replica plated on a master plate 
containing the appropriate antibiotic and finally resuspended in the Taq-polymerase 
master mix (Table 21). The Taq-polymerase requires 60 s/kb for amplification, so the 
elongation time has to be adjusted according to the gene length. A standard PCR 
program is shown in Table 22, page 33.  
  
Table 21. Components for colony PCR 
Component Quantity  
10x Taq Reaction Buffer 1.25 µL 
dNTPs (2 mM) 1.25 µL 
Forward Primer (5 µM) 1.25 µL 
Reverse Primer (5 µM) 1.25 µL 
Taq Polymerase 0.125 µL 
ddH2O ad. 7.375 µL 
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Table 22. Colony PCR program 
Step Temperature (°C) Time (min:sec) 
1. Initial Denaturation 98 04:00 
2. Denaturation  98 00:30 
3. Annealing  55 – 65 00:30 
4. Extension* 72 01:00 /kb 
5. Final Extension 72 04:00 
6. Hold 4 - 
* 25 cycles from step 1 - 4.  
 
 
2.7.9. Colony PCR of S. cerevisiae for isolation of plasmid- and genomic DNA  
Genomic DNA was extracted after the integration was carried out 104.  
One colony was picked or 100 – 200 µL liquid yeast culture was centrifuged down for 
5 min at 14.000 rpm. The supernatant was discarded and the obtained cell pellet used 
for the next step. The cell pellet or colony was resuspended in 50 - 100 μL of 200 mM 
lithium acetate, 1 % w/v SDS solution. The cell suspension was then incubated for 15 
min. at 70 °C. About 150 – 300 μL of 96 - 100 % ethanol was added and the tube 
shortly vortexed. Genomic DNA and cell debris were centrifuged down at 14.000 rpm 
for 5 min. The pellets were washed with 150 – 300 µL 70 % ethanol with a subsequent 
centrifugation step as described in the prior step. The obtained cell pellet was 
resuspended in 50 - 100 μL sterile ddH2O or TE-buffer. The suspension was finally 
centrifuged for 15 – 30 sec. at 10.000 rpm. Use 1 - 2 μL of supernatant for PCR. 
 
Alternatively, the Yeast DNA Extraction Kit (Thermo Scientific) was used and the 
procedure followed according to the manual. 
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2.8. Microbial Methods 
 
2.8.1. Microbial methods for E. coli 
2.8.1.1. Preparation of competent E. coli cells 
Competent E. coli cells were prepared chemically according to 105 by the technician 
Ms. Ines Rahaus. A single colony of E. coli strain was transferred to 10 mL LB medium 
and incubated at 37 °C and 220 rpm overnight. One mL of the overnight culture was 
transferred to new 50 mL LB-medium (with an appropriate antibiotic) and further 
incubated until OD600 reached 0.5 - 0.8. The cell suspension was centrifuged at 8000 
rpm for 10 min. at 4 °C and the obtained cell pellets were resuspended in 10 mL ice-
cold 50 mM CaCl2 solution and centrifugedt under the same conditions. After 
discarding the supernatant, pellets were washed by re-suspending in 20 mL 50 mM 
CaCl2 followed by incubation on ice for 30 min. The last step was repeated using 2 mL 
CaCl2 to resuspend the pellets followed by incubation on ice for 15 min. For long-term 
storage, 140 µL ice-cold sterile glycerin solution (86%) was added per 960 µL cell 
suspension. Aliquots of 50 - 100 μL competent cells were transferred into 1.5 mL tubes 
and directly frozen at -80 °C. 
 
 
2.8.1.2. Transformation of plasmid DNA into E. coli 
For the transformation of plasmid DNA, 50 or 100 μL of frozen competent E. coli DH5α 
or BL21 cells were thawed on ice for about 10 - 15 min. Up to 5 μL (10 – 100 ng), 
plasmid DNA was mixed with 100 µL competent cells and incubated for additional 30 
min on ice. Afterwards, the heat shock was performed by placing the tube containing 
cells and plasmid DNA into a water bath at 42 °C for 45 – 60 seconds. After the heat 
shock, tubes were directly placed on ice for 2 min. Subsequently, 500 µL sterile LB-
medium (Table 5, page 19) was added and the cells were recovered for 60 min by 
shaking at 37 °C and 250 rpm. The recovered cells (20 – 100 µL) were plated out on 
LB-agar plates containing the appropriate antibiotics and incubated overnight at 37 °C.  
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2.8.1.3. Protein expression in E. coli 
E. coli BL21 was grown in LB-medium at 37 °C and 200 rpm. Ampicillin was 
supplemented at a final concentration of 100 µg/mL, while chloramphenicol was at a 
final concentration of 35 µg/mL. 
The starter culture consisted of 5 mL LB-medium and was inoculated with a single 
colony. After 12-16 h of incubation, 2 mL of the starter cultures were transferred to 50 
mL LB-medium (supplemented with ampicillin and chloramphenicol) and incubated 
until OD600 reached 0.6 - 0.8. The protein expression was induced by the addition of 
IPTG to a final concentration of 0.25 mM and the incubation was for 4 h at 25 °C. 
 
 
2.8.1.4. Cell disruption using sonicator 
The pellet, which was received after centrifugation of the 50 mL culture at 5000 rpm 
for 5 min., was resuspended in 3 mL lysis buffer. The cells were then sonicated for 2-
3 min on ice. A centrifugation at 14000 rpm and 4 °C for 15 min resulted in the 
supernatant, i.e. the crude extract. 
 
 
2.8.1.5. Preparation of E. coli cryo-stock 
E. coli cryo-stocks were prepared by picking a single positively transformed colony 
from a LB-agar plate (Table 5, page 19) and inoculating it into 5 mL LB-medium 
containing appropriate antibiotics. The cells were grown overnight at 37 °C and 230 
rpm. E. coli cell suspension (0.5 mL) was mixed within a cryo-stock tube with 0.5 mL 
sterile 50 % glycerol (v/v) solution. The tubes were vortexed vigorously prior to long-
term storage at -80 °C. 
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2.8.2. Microbial methods for S. cerevisiae expression system 
2.8.2.1. Preparation of competent S. cerevisiae cells 
Preparation and transformation of competent S. cerevisiae cells were carried out 
according to 106. 
For the preparation of plasmid-free S. cerevisiae competent cells, either 25 mL pre-
warmed (30 °C) 2x YPD-medium (Table 5, page 19) was inoculated with a single 
colony picked from a YPD-plate (Table 5, page 19) or a sterile 100 mL flask was 
inoculated with a swab taken from a cryo-stock (section 2.8.2.6., page 38). For S. 
cerevisiae cells containing URA-plasmid-DNA, either 25 mL pre-warmed SGI-medium 
(Table 5, page 19) (30 °C)  was inoculated with a single colony picked from an SGI-
plate (Table 5, page 19) or a sterile 100 mL flask was inoculated with a swab taken 
from a cryo-stock. The pre-cultures were incubated overnight at 30 °C and 220 rpm. A 
main culture with OD600nm = 0.1 – 0.2 was prepared in pre-warmed 2x YPD-medium 
from the pre-culture. The main culture was further grown as mentioned previously for 
4 – 6 h until an OD600nm = 1.0 – 1.5 was reached. The cells were harvested by 
centrifugation at 3.000 rpm for 5 min at RT, washed once with 50 mL and a second 
time with 10 mL sterile water. The obtained cell pellets were resuspended in 1 mL 
sterile “frozen competent cell” (FCC) solution (5% v/v glycerol and 10% v/v DMSO). 
Aliquots of 50 μL competent cells were wrapped into paper towels and directly frozen 
at -80 °C. The paper towels are required to guarantee slow freezing of the competent 
cells. Next day, the paper towels were removed and the competent cells were further 
stored at – 80 °C until use.    
 
 
2.8.2.2. Transformation of plasmid DNA into S. cerevisiae 
A 50 µL aliquot of frozen competent cells was thawn for 15 – 30 sec. in a water bath 
at 37 °C. The tube was subsequently centrifuged at 13.000 rpm for 2 min and the 
supernatant removed. Meanwhile, a 50 µL aliquot of salmon sperm (carrier ssDNA; 2.0 
mg/mL) was boiled at 95 °C for 5 min and directly chilled on ice until use. The 
transformation mix, prepared as described in Table 23, page 37, was used to 
resuspend the cell pellet with subsequent incubation in a 42 °C water bath for 
approximately 60 min. Afterwards, the cell suspension was centrifuged at 13.000 rpm 
for 30 seconds and the cell pellet was resuspended in 500 µL sterile water. 100 µL 
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were plated out on SGI-plates (Table 5, page 19) with a following incubation at 30 °C 
for 3 – 5 days.  
  
Table 23. S. cerevisiae transformation mix 
Composition Quantitiy  
PEG 3350 (50% (w/v)) (autoclaved) 260 µL 
LiAc 1.0 M (sterile filtrated) 36 µL 
carrier ssDNA (2.0 mg/mL)  50 µL 
Plasmid DNA (>1 µg) plus sterile water 14 µL 
Total volume 360 µL 
 
 
2.8.2.3. Carbon source variation of the cultivation media  
To test which carbon source is the most efficient for recombinant protein expression in 
S. cerevisiae, glucose and sucrose as carbon sources were tested. To do so, a 
pESC_URA_GFP plasmid was transformed in S. cerevisiae cells (section 2.8.2.2., 
page 36) and a pre-culture was grown for 24 h at 30 °C and 220 rpm in SGI-medium. 
(Table 5, page 19). After 24 h, 1 mL of the pre-culture was transferred into a new flask 
containing again either SGI or SSI medium (sucrose). Following 24 h of growth, the 
GFP expression was induced by adding sterile-filtrated galactose (2 % final 
concentration). The GFP fluorescence was investigated under a confocal fluorescence 
microscope in collaboration with Dr. David Kaufholdt (Prof. Dr. Robert Hänsch group, 
Institut of Plant Biology, TU-Braunschweig). 
  
 
2.8.2.4. Protein expression in S. cerevisiae using Gal1/10 promoter 
S. cerevisiae cells were grown at 30 °C and 220 rpm. For cells grown on plates as well 
as for the starter cultures of S. cerevisiae, either SGI medium or SGI plates were used. 
The main culture was grown in YPSE-medium. 
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The starter culture consisted of 10 mL SGI-medium in a 100 mL flask and was 
inoculated with a colony or cryo-stock (section 2.8.2.6., page 38). After 24 - 48 h of 
incubation, the main-culture was initiated by inoculating a 1L flask containing 100 mL 
YPSE-medium with about 5 mL of the starter culture. After incubation for 24 h, protein 
expression was induced by adding 10 mL sterile 20 % galactose solution and finally 
incubated for another 24 h. Afterwards, the culture was centrifuged using a 50 mL 
Falcon tube, the supernatant discarded and the pellet directly used for cell disruption 
(section 2.8.2.7., page 38) or stored at – 80 °C until use.  
 
 
2.8.2.5. Protein expression in S. cerevisiae using pTEF1/pPKG1 promoter 
A pre-culture was prepared as described in the previous section (section 2.8.2.4., page 
37). After 24 - 48 h in the incubator, the main-culture was prepared by inoculating 
sterile 100 mL YPSE-medium in a 1 L flask with about 5 mL of the pre-culture. The 
main-culture was incubated for 24 h. After 24 h, new sterile sucrose solution was added 
to the culture and cultivated for another 24 h. Afterwards, the culture was centrifuged 
using a 50 mL Falcon tube, the supernatant discarded and the pellet directly used for 
cell disruption (section 2.8.2.7., page 38) or stored at – 80 °C until use.  
 
 
2.8.2.6. Preparation of S. cerevisiae cryo-stocks 
S. cerevisiae cryo-stocks were prepared by inoculating 10 mL SGI-medium with a 
single colony from a SGI-plate (Table 5, page 19). The cultures were grown overnight 
at 30 °C and 220 rpm. 0.5 mL S. cerevisiae cell suspension was mixed with 0.5 mL 
sterile 50 % glycerol (w/w) solution in a cryo-tube. The tubes were vortexed vigorously 
prior to long time storage at -80 °C. 
 
 
2.8.2.7. Preparation of S. cerevisiae microsomal fraction  
Yeast microsomal fractions were obtained as described with some minor modifications 
107. The obtained yeast cell pellet (section 2.8.2.4., page 37) was mixed with an equal 
amount (w/v) of TES-buffer (Table 24, page 39). About 3 mL was added to a 15 mL 
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Falcon tube containing 2 – 3 spatula of acid-washed glass beads (425 - 600 µm, 
Sigma). The cell suspension was then vortexed for about 30 min at 4 °C. To remove 
cells, cell debris, nuclei and glass beads, the cell suspension was centrifuged at 5000 
rpm for 5 min at 4 °C. The supernatant (crude protein) was then transferred into a new 
15 mL Falcon tube and kept on ice until further usage. The whole procedure was 
repeated once more. To obtain a microsomal pellet, ultracentrifugation was carried out 
at 100.000 g for 1 h at 4 °C using the supernatant obtained from the previous step. The 
obtained yeast microsomal pellet was diluted in TEG buffer (Table 24, page 39) to give 
a protein content of either 25 µg/µL (HpPT2) or 50 µg/µL (HpPT6). Protein 
concentrations were determined either by the method of Bradford (1976) calibrated 
with bovine serum albumin as a standard or by the Nanodrop (setting: BSA as 
standard). 
 
Table 24. Yeast cell disruption and storage buffer 
Buffer  Composition 
TES buffer: pH 7.4 
Tris-HCl 50 mM 
EDTA 1 mM 
Sorbitol 0.6 mM 
TEG buffer: pH 7.4 
Tris-HCl 50 mM 
EDTA 1 mM 
Glycerol 20% 
 
 
2.8.2.8. Bradford protein assay 
All protein concentrations were measured either according to Bradford 108 or using the 
SimpliNano (protein setting: BSA). Firstly, 900 µL Bradford solution was pipetted into 
a plastic cuvette with subsequent addition of 98 µL buffer, in which the protein is 
dissolved. Afterwards, 2 µL protein was added, mixed and further incubated for 5 min. 
The absorbance was measured at 595 nm against a blank containing Bradford solution 
(900 µL) and 100 µL buffer. The protein concentration was then calculated based on a 
BSA calibration curve. 
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Table 25. Composition of Bradford solution 
Component Quantity 
Coomassie-Brilliant blue G250 100 mg/L 
Ethanol abs. (96 %) 50 mL 
Phosphoric acid (85 %) 100 mL 
ddH2O ad. 1 L 
 
 
2.8.2.9. DASGIP® bioreactor cultivation  
The yeast strains containing the genes HpIBCL and HpIBS were cultivated in the 
DASGIP® bioreactor systems to compare the productivity between the genes 
expressed either episomally or genome-integrated. In total, four different strains were 
cultivated: 1. pESC_URA_IBCLepi_IBS, 2. pESC_URA_IBCLgint_IBS, 3. 
pESC_URA_BZCLepi_IBS, 4. pESC_URA_BZCLgint_IBS. All genes used were under 
the control of the constitutive promoters pTEF1/pPGK1. A pre-culture was prepared in 
SGI-medium by picking single colonies and cultivating them in 50 mL SGI-medium at 
30 °C and 180 rpm for about 24 h.  
The reactor setup consisted of the following components: DASGIP® cultivation system 
(Bioblock CWD 4), temperature control module (TC4 SC4), gas regulation module 
(MX4/4), pH and DO control module (PH4 PO4), pump module (MP8) (DASGIP® 
Information and Process Technology, Jülich, Germany); three bioreactors (Dasgip® - 
Sr0400ss Advanced Stirrer 150 – 300 mL, Magnetic Drive) equipped with a pH sensor 
(Mettler Toledo® MTI D12 mm, L225 mm), a DO sensor (Hamilton, VisiFerm DO 225) 
and an exhaust condenser (DASGIP®, AD 12 mm, filter: Sartorius stedim Midisart® 
2000, 0.2 µm PTFE). The bioreactors were filled with 250 mL SGI-medium and initiated 
with a pre-culture to reach an OD600 between 0.1 – 0.2. The reactors were operated at 
30 °C, flushed with 15 sL/h air at 40 rpm (stirrer setting: BMXD) for about 48 – 60 h.  
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2.9. Biochemical Methods 
 
2.9.1. Isobutyrophenone synthase (HpIBS) assay 
This work was performed in cooperation with Dr. Benye Liu and the Bachelor students 
David Quast and Henning Ummethum 109,110. The general activity screening of full-
length and truncated versions of HpIBS was performed in a total volume of 250 µL 
containing 100 mM Tris buffer (pH 7.5), 7.62 µM isobutyryl-CoA, 18.76 µM malonyl-
CoA and 100 µg yeast crude protein, determined by Bradford (section 2.8.2.8, page 
39). The mixture was incubated for 1 h at 37 °C. The reaction mixture was extracted 
and analyzed by HPLC (section 2.11.2, page 53).  
 
Table 26. Composition of the HpIBS assay  
Component  Concentration  
Tris-HCl (250 mM) pH 7.5 100 mM  
Protein  100 - 200 μg  
Isobutyryl-CoA  7.62 μM  
Malonyl-CoA  18.76 μM  
   
 
2.9.2. Aromatic prenyltransferases investigated in this study 
Templates used in the current study were kindly provided by Dr. Fiesel and Dr. Gaid 
(HcPT1–3 and HpPT1 – 9/pFastBac1 plasmids) 34,111,112. All PTs were cloned into the 
yeast expression vector pESC-URA or pESC-HIS and transformed into the yeast strain 
INVSC.1. 
  
2.9.2.1. Prenyltransferase screening experiments  
The general PT activity screening of full-length and truncated versions was performed 
in a total volume of 250 µL containing 100 mM PBS buffer (pH 7), 100 mM MgCl2, 10 
mM NaF, 200 µM substrates, 200 µM DMAPP or GPP and 100 µg yeast crude protein. 
The mixture was incubated for 2 h at 30 °C under continuous shaking at 200 rpm. The 
products were extracted and analyzed by HPLC (section 2.11.2, page 53). After 
stopping the reaction with 50 µL 2 N HCl, the assay mixture was extracted twice with 
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ethyl acetate using double the reaction volume each time. The ethyl acetate extracts 
were collected and air-dried. The obtained residue was resuspended in 100 µL of either 
DMSO or methanol (HPLC grade), of which a 25 µL aliquot was analyzed by HPLC 
(section 2.11.2., page 53).  
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Figure 11. PT substrates used for incubations in this study.
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2.9.2.2. Kinetic characterization of HpPT2 
The standard enzyme assays were carried out in a total volume of 125 µL containing 
100 mM Tris buffer (pH 8), 10 mM MgCl2, 400 µM Substrate, 600 µM GPP and 100 µg 
yeast microsomal protein. The mixture was incubated for 10 min at 40 °C and 700 rpm. 
All substrates were dissolved in methanol or DMSO.  
 
 
2.9.2.3. Kinetic characterization of HpPT6 
The standard enzyme assays were carried out in a total volume of 125 µL containing 
100 mM Tris-buffer (pH 9), 10 mM CaCl2, 250 µM substrate, 400 µM DMAPP, 2.5 µL 
DMSO to solubilize the substrate and 400 µg yeast microsomal protein. The mixture 
was incubated for 10 min at 50 °C and 700 rpm. All substrates were mainly dissolved 
in methanol and/or DMSO.  
 
 
2.9.2.4. Determination of KM and Vmax 
The Michaelis-Menten equation (Figure 12, page 45) describes the velocity (Vmax) and 
affinity of an enzyme, which depend on the substrate concentration. The enzymatic 
affinity towards a substrate is expressed by the term Michaelis constant (KM). The 
maximum enzymatic reaction velocity is expressed by the term Vmax.     
The apparent KM values for the most preferred substrates of HpPT2 and HpPT6 were 
determined by using varying concentrations of acceptor substrate and co-substrate 
(DMAPP, GPP). The acceptor substrate ranged from 5 – 400 µM while keeping the 
GPP (600 µM) and DMAPP (400 µM) concentrations constant. The apparent KM values 
for GPP and DMAPP were quantified by using concentrations ranging from 5 – 1500 
µM with constant acceptor concentrations (400 µM and 250 µM for HpPT2 and HpPT6, 
respectively). All measurements were done in three technical triplicates. Extraction and 
quantification of the enzymatic products were done as mentioned above (section 
2.9.2.1., page 41). All KM and Vmax values were estimated using either OriginPro 
(Version 2016G) or Hyper32 (Version 1.0.0, Hyper) employing the “Michaelis-Menten” 
equation (Figure 12). 
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Figure 12: Michaelis-Menten equation. 
 
 
2.9.2.5. Large-scale incubation and purification for NMR structure elucidation 
To obtain enough amount of a product for verifying the structure by NMR, large-scale 
incubation was performed. The standard assay volume was increased at least 200 – 
250 times. After incubation, the reaction was stopped by the addition of 2 mL 1N HCl. 
The product was extracted 3 times with an amount of ethyl acetate equal to the 
incubation mixture. The ethyl acetate phase was dried under nitrogen gas, dissolved 
in 100 µL MeOH (HPLC grade) and purified via HPLC. The collected fractions were 
again dried under nitrogen until the organic phase (methanol) was removed. The 
aqueous phase was then finally dried by lyophilization. After freeze-drying, the 
obtained enzymatic product was dissolved in deuterated solvents (CDCL3 or CD3OD; 
Deutero, Kastellaun, Germany).  
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2.10. Chemical Methods 
 
2.10.1. Synthesis and purification of dimethylallypyrophosphate (DMAPP) 
The synthesis of DMAPP was carried out according to the following literature 113. The 
synthesis was done in collaboration with Dr. Mariam Gaid, Dr. Eline Biedermann, and 
Mohamed Nagia, whereas MS spectrometry was carried out together with Dr. Till 
Beuerle.  
 
 
2.10.1.1. Synthesis of DMAPP 
A 100 mL round-flask was heat-dried overnight at 150 °C for residual water removal 
before starting the synthesis. Tris(tetrabutylammonium)hydrogen pyrophosphate 97 % 
(5.64 mmol, Sigma) was resuspended in 20 mL water-free acetonitrile (dried over 
anhydrous Na2SO4, Zentrales Lager für Chemikalien [ZLChem], TU Braunschweig) by 
stirring at room temperature. Dimethylallylchloride (345 μl, Sigma) 97 % (2.91 mmol) 
was added, the flask closed (rubber) to avoid the entrance of water and further mixed 
for additional 2 h at room temperature. The acetonitrile was subsequently removed 
using a rotary evaporator and a water bath at 40 °C and the remaining pale-yellow 
viscous residue was stored at -20 °C. 
 
 
Figure 13. Synthesis of DMAPP according to Woodside et al. (1993). 
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2.10.1.2. Purification of DMAPP 
Preparation of the cation-exchange column 
For the conversion of the acidified material Dowex AG 50W-X8 (100–200-mesh, H+ 
form) into the ammonium counterpart, 188 mL was washed four times with 
concentrated ammonium hydroxide solution. The material was washed with 200 mL 
ddH2O until pH 7 was reached. Finally, the material was packed into a column and 
equilibrated with 2 x 200 mL cation-exchange buffer (Table 27). 
 
 
Preparation of Whatman CF11 fibrous cellulose column  
For the preparation of a Whatman CF11 fibrous cellulose column, 1 L cellulose powder 
was mixed with 700 mL ddH2O water and stirred with a glass rod for few minutes. The 
suspension was allowed to settle for about 30 min with subsequent decanting of the 
water phase. The previous steps were repeated with 2 x 700 mL portions of 0.1 N 
hydrochloric acid, 2 x 700 mL portions of deionized water, 2 x 700 mL portions of 0.1 
N sodium hydroxide, 2 x 700 mL portions of deionized water, and 2 x 700 mL portions 
of 1:1 (v/v) isopropyl alcohol : water (overnight storage at 4 °C). After packaging the 
column, the cellulose material was first washed with 1.3 L acetonitrile and then with 
1.3 L of a 1:1 (v/v) isopropyl alcohol: water mixture. Finally, the cellulose column was 
equilibrated with 1.3 L chromatography buffer (Table 27).       
  
Table 27. Ion-exchange buffer for DMAPP purification 
Buffer  Composition Quantity  
Cation-exchange buffer  
           (25 mM) 
Ammonium carbonate 2 g  
Isopropanol 20 mL 
ddH2O 980 mL 
Chromatography – buffer 
          (50 mM) 
Ammonium carbonate 4 g  
Isopropanol 500 mL 
Acetonitrile  250 mL 
ddH2O 250 mL 
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2.10.1.3. Purification of DMAPP after the synthesis 
The remaining pale-yellow residue from the previous step was dissolved in 3 mL 
cation-exchange buffer (Table 27, page 47) and the obtained clear solution was loaded 
onto the previously prepared cation-exchange column. The flask was washed 2 x with 
5 mL cation-exchange buffer to collect the remaining synthetic DMAPP and then 
loaded onto the column. The elution was carried out with 360 mL cation-exchange 
buffer (Table 27, page 47) and the eluent was collected in a 500 mL flask. The collected 
fractions were frozen in liquid N2 and further lyophilized for 18 – 24 h until a white solid 
powder remained. The remaining material was dissolved in 5 mL of 50 mM ammonium 
bicarbonate and the clear solution was transferred to a 50 mL Falcon tube. Afterwards, 
20 mL of a 1:1 (v/v) acetonitrile: isopropyl alcohol mixture was added and the tube was 
vigorously vortexed until a white precipitate was formed. The suspension was 
centrifuged for 5 min at 2000 rpm until a clear solution occurred. The supernatant was 
discarded and the white residue washed twice with 5 mL of 50 mM ammonium 
bicarbonate. Three further extractions were carried out by the addition of 2 mL 50 mM 
ammonium bicarbonate and 8 mL 1:1 (v/v) acetonitrile: isopropyl alcohol. The 
supernatants were combined and concentrated up to about 5 mL using a rotary 
evaporator and a water bath at 40 °C. The obtained concentrated solution was 
dissolved in an equal amount of chromatography buffer (Table 27, page 47) and loaded 
onto the Whatman CF11 fibrous cellulose column. The flask was washed three times 
with 5 mL chromatography buffer and loaded on the column. The product was eluted 
using 900 – 1500 mL chromatography buffer, fractions of about 20 mL being collected. 
Every second fraction was analyzed by thin-layer chromatography (DC-plates 
cellulose, 20 x 20 cm, layer thickness 0.1 mm; Merck Darmstadt, Germany) using the 
chromatography buffer as mobile phase. After the thin layer chromatography, the plate 
was sprayed with a freshly prepared sulfosalicylic acid solution (Table 28, page 49), 
air-dried, followed by spraying with freshly prepared iron(III)-chloride solution (Table 
28, page 49). Phosphate-containing compounds appear as white dots on a pink 
background (section 3.1.1., page 57). All fractions containing the target product were 
pooled, concentrated up to about 120 mL (rotary evaporator at 40 °C), frozen in liquid 
N2 and further lyophilized for 18 – 24 h until a white flocculent solid remained. Aliquots 
containing 1 mL of 50 mM DMAPP were prepared by dissolving the previously obtained 
material in methanol:ammonia 10 mM (7:3) and stored at -80 °C until use. The 
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formation of DMAPP and its purity were further verified via MS-spectrometry (2.11.5., 
page 55).    
  
Table 28. Spray solution for the detection of DMAPP after chromatography 
Solution  Composition Quantity  
Sulfosalicylacid solution 
5 - Sulfosalicacid 1 g  
Ethanol 60 mL 
ddH2O 40 mL 
Iron(III)- chlorid solution 
Iron(III)- chloride 0.2 g 
Ethanol 80 mL 
ddH2O 20 mL 
 
 
2.10.2. Synthesis of PIBP and PIVP 
The synthesis of phlorisobutyrophenone (PIBP) was done according to 114 with minor 
modifications:  
Anhydrous phloroglucinol (10.0 g, 79.3 mmol, Merck, Germany) was dissolved by 
stirring in 80 mL nitrobenzene (Merck, Germany). AlCl3 (42.3 g, 317 mmol, Merck, 
Germany) was added in three portions until the solution turned into a pale brown 
solution. The complete reaction mixture was stirred for at least additional 30 min at RT 
until a clear solution was obtained. Afterwards, 9.14 mL (87.2 mmol) of the alkyl-halide 
isobutyryl-chloride solution (Sigma, Germany) was added stepwise and the reaction 
mixture heated up to 65 °C using an oil bath for about 21 h. The reaction was stopped 
by pouring it into ~200 mL ice-water. The product was then extracted from the reaction 
mixture using 3 x 500 mL EtOAc. The organic phase was concentrated up until a thick 
oily residue was formed. To remove the AlCl3 from the reaction mixture, the oily residue 
was loaded and purified over a celite column using EtOAc as an eluent. The effluent 
was concentrated up again and further purified by column chromatography using SiO2 
(250 g) and petrol ether/EtOAc (4:1 → 2:1) as eluent. For structure elucidation or 
enzymatic incubations, PIBP was further purified by semi-preparative HPLC (section 
2.11.4., page 55). The structure was validated by MS spectrometry (section 2.11.5., 
page 55) and 1H-NMR and 13C-NMR (section 2.11.6., page 56).   
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PIVP was synthesized according to the procedure described in this section, except that 
only 1/5 of this amount was synthesized and isovaleryl-chloride was used as alkyl-
halide.   
 
 
2.10.3. Synthesis of 2-methylbutanoyl-phloroglucinol (2-MBP) 
The synthesis of 1-(2,4,6-trihydroxyphenyl)-2S-methylbutanone was adapted from the 
procedure described elsewhere 115.      
    
2.10.3.1. Synthesis of (S)-2-methylbutanoic chloride 
(S)-(+)-2-methylbutanoic acid (4.9 mmol in 0.5 mL; Alfa Aesar, Germany) was added 
to a 50 mL round bottom flask and stirred at room temperature at 150 rpm. Afterwards, 
0.5 mL oxalyl-chloride (5.9 mmol; Sigma, Germany) was added, the bottom flask 
closed and the mixture stirred at room temperature for about 30 min. After 30 min, 2 
ml dichloromethane was added and the whole mixture proceeded to the second step 
as described below in section 2. The synthesized (S)-2-methylbutanoic chloride was 
used without purification. 
 
2.10.3.2. Synthesis of 1-(2,4,6-trihydroxyphenyl)-2S-methylbutanone 
For the final synthesis, 0.5 g phloroglucinol (3.9 mmol) was dissolved in a mixture of 3 
mL dichloromethane and 5 mL nitromethane. Aluminum-trichloride (2.1 g ~ 15.6 mmol) 
was added in three portions and the mixture was stirred at room temperature for 30 
min. After 30 min, the freshly prepared (S)-2-methylbutanoic-chloride solution (from 
step 1) was added slowly and stirred for another 5 min at room temperature. The 
mixture was refluxed for 16 h at 40 °C in an oil bath. The mixture was cooled down to 
room temperature and the reaction stopped with 100 mL ice-cold water. The mixture 
was acidified using HCl until pH 1 - 2 was reached. Volatile organic solvents were 
evaporated under N2. The reaction mixture was extracted three times with 150 mL 
EtOAc with subsequent evaporation under N2. The remaining solution was dissolved 
in methanol (HPLC grade) and purified via semi-preparative HPLC. The structure was 
confirmed via MS-spectrometry and NMR-spectroscopy.    
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2.10.4. Synthesis of 3-prenyl-PIBP  
The synthesis of 3-prenyl-PIBP was carried out according to Li Xiao et al. (1998). In a 
round bottom flask, PIBP 0.5 g (0.25 M) was dissolved in 10 mL 4.9 mmol KOH (2.8 
mg), stirred and cooled on ice. Prenyl-bromide 450 µL (0.3 M; Sigma, Germany) was 
added dropwise over 5 min while warming up to room temperature. After stirring for 
about 3 – 4 h, the reaction was stopped by adding 10 ml ice-cold HCl-acidified (pH 2) 
water. Finally, the 3-prenyl-PIBP product was extracted three times with ethyl acetate 
(30 mL). The combined organic phases were evaporated under N2 and purified by 
HPLC (section 2.11.4., page 53). 
 
 
2.10.5. Synthesis of 3-geranylated PIBP, PAP, PBP, PIVP, and 2-MBP 
The synthesis were carried out according to the following publication 116, here 
exemplified by the synthesis of 3-geranyl-PIBP.  
A mixture of 1 molar equivalent of PIBP (synthesized as described in section 2.10.2., 
page 49) (100 mM), 1 molar equivalent of geranyl-bromide (100 mM, Sigma, Germany) 
and 2 M equivalents of K2CO3 (0,27 g) in 10 mL water-free acetone (dried over sodium 
sulfate) was stirred at RT for 24 h under reflux. Firstly, PIBP was dissolved in acetone 
and cooled down in an ice bath prior to addition of geranyl-bromide (exothermic 
reaction!). Geranyl-bromide was then added dropwise within about 5 min and the 
reaction was carried out under reflux for 24 h. After 24 h, the acetone was evaporated 
under N2 and the reaction stopped by the addition of about 2 mL 2 N HCl (pH should 
be about 3 – 4). Chemically synthesized 3-geranyl-PIBP was extracted 3 times with 
about 5 mL EtOAc. Following extraction, EtOAc was evaporated under N2 and the 
remaining oily residue dissolved in MeOH (HPLC grade) and purified via semi-
preparative HPLC (section 2.11.4., page 55). Structure verification was carried out by 
MS–spectrometry. The enzymatic product of HpPT2, which was NMR verified and 
identified as 3-geranyl-PIBP, was used as an authentic reference compound for 
chromatography. 
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2.10.6. Synthesis of 1,3,6,7-tetrahydroxyxanthone 
The synthesis of 1,3,6,7-tetrahydroxyxanthone was performed according to 117. 
Mangiferin (30 mg; Avachem, San Antonio, USA) was dissolved in 150 µL HBr and 
120 µL phenol, heated up at 150 °C for 6 h under reflux. Then, 3 mL of saturated 
sodium bicarbonate solution was added to the mixture to obtain 1,3,6,7-
tetrahydroxyxanthone. The product was extracted 3 times with about 20 mL EtOAc. 
Following extraction, EtOAc was evaporated under N2 and the remaining oily residue 
dissolved in MeOH (HPLC grade) and purified via semi-preparative HPLC (section 
2.11.4., page 55). Structure verification was carried out by MS spectrometry. 
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2.11. Analytical Methods 
 
2.11.1. HPLC theoretical background 
High-performance liquid chromatography is one of the most commonly used methods 
for the separation and quantification of compounds in natural science. For the reversed 
phase separation principle, the separation is based on the interaction of the analyte 
dissolved in the polar mobile phase and the non-polar stationary phase. Common 
mobile phases are water, methanol and acetonitrile and columns containing modified 
silica (SiO2) microparticles (typically a size 1.5 – 5 µm) are the stationary phase. For 
the separation of a mixture of hydrophilic and hydrophobic analytes, C18 modified 
reversed phase (RP) columns are the most widely spread columns. For the detection 
of the analytes, DAD is the most common UV/VIS detectors due to the ability to record 
the UV (ultraviolet) spectra ranging from 190 to 390 nm and the VIS spectra ranging 
from 390 nm to 700 nm. These types of detectors guarantee the detection of aromatic 
and unsaturated conjugated compounds. 
 
 
2.11.2. HPLC Measurements  
In the current study, three different types of HPLC machines were used for analytical 
purposes; the Agilent 1260 Infinity Quaternary LC System (Agilent Technologies; 
Santa Clara, CA, USA) with a diode array detector (G4212A); the Waters 2795 
Separations Module with a Waters 2996 PDA Detector (Waters, Germany). They were 
equipped with either a Symmetry® C18 column (4.6 x 75 mm, 3.5 µm; Waters, Germany) 
or a ZORBAX SB-C18 (3.5 µm, 4.6 × 150 mm; Agilent) column. 
Bidest water containing 0.1 % formic acid (solvent A) and methanol (solvent B) were 
used as solvents. The flow rate was set to 1 mL/min (Waters column) or 0.5 mL/min 
(ZORBAX column) with the following linear gradient (v/v) for solvent B: 0 to 6 min., 
40% to 60%; 6 to 10 min., 60% to 85 %; 10 to 11 min., 85% to 95%; 11 to 16 min., 95 
to 100%. The column was washed with 100% solvent B for 3 min and then equilibrated 
with 40% solvent B for 5 min. The third HPLC was used for semi-preparative purposes 
(section 2.11.4., page 55).  
 
Material and Methods 
54 
 
2.11.3. Calibration curve:  
Three PIBP (Stock 100 mg/mL) calibration curves have been prepared according to 
the following dilution series as described in Table 29. Each dilution (20 µL) series was 
analyzed by HPLC and the detection wavelength was set at 286 nm. 
 
Table 29. Composition of the calibration curve for PIBP, PIVP, and 2-MBP  
No. Final in HPLC (µg) Vial Stock (µg/mL) dilution series 
1 0.1 5 1/10 of 50 
2 0.2 10 1/10 of 100 
3 0.5 25 1/10 of 250 
4 1.0 50 1/10 of 500 
5 2.0 100 1/10 of 1mg 
6 5.0 250 1/1 of 500 
7 10.0 500 1/2 of 1mg 
    1000 1/100 of 100 mg/mL 
 
Additional calibration curves have been prepared for the other chemically synthesized 
compounds with a concentration of 50 mg/mL: 3-geranyl-PIBP, 3-geranyl-PIVP, 3-
geranyl-PAP, 3-geranyl-2-MBP, 3-geranyl-PBP. Due to the low availability of the 
compounds, only three dilution series have been prepared and injected with different 
injection volumes. Dilution series were analyzed by HPLC and the detection was 
performed at the compound-specific wavelengths (nm).  
 
Table 30: Composition of calibration curves for 3-g-PIBP, 3-g-PIVP, 3-g-PAP, 3-
g-PBP, 3-g-2-MBP 
No. Final in HPLC (µg) Vial Stock (µg/mL) injection Volume 
1 0.025 2.5 10 µL 
2 0.050 2.5 20 µL 
3 0.100 2.5 40 µL 
4 0.250 25 10 µL 
5 0.500 25 20 µL 
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6 1.000 25 40 µL 
7 2.500 250 10 µL 
 
 
2.11.4. Semi-preparative HPLC 
For a large-scale purification of enzymatically or chemically synthesized products, 
semi-preparative HPLC was used. VWR Hitachi HPLC L-2130 (VWR) with a diode 
array detector (L-2455) equipped with either a Hyperclone 5µ ODS (C18) 120A column 
or a Phenomenex column (10 x 250 mm, 5 µm; Phenomenex, Germany). 
Bidest water containing 0.1 % formic acid (solvent A) and methanol (solvent B) was 
used as a solvent. The flow rate was set to 5 mL/min with a linear gradient (v/v), which 
was as follows for solvent B: 0 to 4 min, 40% to 75%; 4 to 39 min, 75% to 86 %; 39 to 
40 min, 86% to 100%; 40 to 41 min, 100% isocratic elution for 5 min. The column was 
washed with 100% solvent B for 5 min and then equilibrated with 40% solvent B for 3 
min. Depending on the compound, some modifications had to be adjusted based on 
the previously described method.  
 
 
2.11.5. Mass spectrometry 
All MS measurements of the current Ph.D. project were carried out in cooperation with 
Dr. Till Beuerle. Each analysis was performed using the QTrap 3200 System (Applied 
Biosystems/MDS SCIEX, Darmstadt; II6).  The Analyst software (version 1.6.2; Applied 
Biosystems/MDS Sciex, Waltham, MA, USA) served for data acquisition and 
processing. The samples were HPLC-purified and prepared in concentrations of about 
5 - 10 µg/mL. If required, they were dried and finally dissolved in 500 µL methanol (MS-
Grade) before injection. All samples were injected into the electrospray-ionization 
source (ESI, Turbo V) using a Hamilton syringe pump with 5 µL/min. 
The target molecular-ion peaks [M + H]+ or [M - H]- were further analyzed by MS2 
experiments in the enhanced product ion (EPI) mode of the instrument using nitrogen 
gas for collision-induced dissociation at the high-level setting.  
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2.11.6. NMR spectroscopy  
All NMR samples were analyzed and evaluated in cooperation with Prof. Dr. Ludger 
Ernst (Zentrales NMR-Labor, Technische Universität Braunschweig). 13C-NMR and 1H-
NMR analyses were carried out on a Bruker Avance II 600 spectrometer using CDCl3 
or CD3SOCD3 (Deutero, Kastellaun, Germany) as solvents. Purified samples (2 mg) 
were stored at -20 °C in the dark until analysis. Enzymatic products for NMR-
spectroscopy were prepared as described under section (section 2.11.2., page 45). 
Detailed information is described in the following sections as prepared by. Prof. Dr. 
Ludger Ernst. 
1H and 13C NMR spectra of grr133194–grr133197 (Appendix) were recorded at 500.3 
and 125.8 MHz, respectively, on an Avance III HD 500 spectrometer with a Prodigy 
probehead (nitrogen-cooled) from Bruker BioSpin (Rheinstetten, Germany). The 
spectra of grr132394, grr133479, grr133480 and gam129944 (Appendix) were 
recorded on an Avance II 600 spectrometer with a TCI cryo probehead (helium-cooled) 
at 600.1 and 150.9 MHz, respectively. The solvents were dimethylsulfoxide-d6 or 
chloroform-d at concentrations < 5 mg/0.45 mL in 5 mm o. d. NMR tubes. Chemical 
shifts are reported in δ units (ppm). They were measured relative to tetramethylsilane 
(TMS, δH = 0.00 ppm) and to the solvent CDCl3 (δC = 77.01 ppm) and DMSO-d6 (δC = 
39.50 ppm), respectively. Assignment techniques used throughout were DEPT-135 
(distortionless enhancement by polarization transfer), H,C-HSQC (heteronuclear 
single quantum correlation) and H,C-HMBC (heteronuclear multiple-bond correlation). 
To facilitate assignments in difficult cases, H,H-COSY (correlation spectroscopy) or 
H,H-NOESY (nuclear Overhauser effect spectroscopy) spectra were also recorded. 
Digital resolutions in the two-dimensional NMR spectra were chosen small enough to 
permit the distinction of cross-peaks with similar chemical shifts (if possible). The 
mixing time in the NOESY experiment was 1.0 s. The HSQC and HMBC experiments 
were optimized for C,H-coupling constants of 145 and 8 Hz, respectively.
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3. Results 
 
3.1. Chemical synthesis of potential substrates 
 
3.1.1. Synthesis of DMAPP 
Plant-derived aromatic prenyltransferase (PT) enzymes transfer prenyl moieties, such 
as C5 (dimethylallyl), C10 (geranyl), C15 (farnesyl) or C20 (geranylgeranyl), to their 
acceptors, while forming C-C, C-N or C-O bonds 74,76. In this work, DMAPP and GPP 
(provided by Mohamed Nagia) were required as isoprenoid donors to perform in vitro 
enzymatic assays. The synthesis was carried out according to Woodside et al. (1993). 
Dimethylallylchlorid was phosphorylated by tris(tetrabutylammonium)hydrogen 
pyrophosphate, followed by purification via a Whatman CF11 fibrous cellulose column. 
In total, 80 fractions (10-15 mL) were collected and every second fraction was analyzed 
by thin-layer chromatography (TLC; cellulose plates). The phosphate group of DMAPP 
was visualized by spraying the plates with a sulfosalicylic acid solution and then 
iron(III)-chlorid solution. Fractions containing DMAPP appeared white on a pink 
background (Figure 14).  
 
 
Figure 14. A TLC plate after visualization of chemically synthesized prenyl donors in fractions of 
cellulose column chromatography. 
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All fractions containing DMAPP (26-42) were collected, concentrated up and 
lyophilized for 18–24 h until a white flocculent solid remained. In total, 640 mg DMAPP 
was obtained and dissolved in methanol:10 mM ammonia = 7:3, giving a solution of a 
final concentration of 50 mM DMAPP, which was stored at -80 °C until use. Structure 
validation was carried out by mass-spectrometry using a 10 µg/mL DMAPP methanolic 
solution. Upon applying an ESI - MS2 analysis (collision energy of -50 V), the molecular 
ion [M - H]- was detected at m/z = 245.0, which corresponded to the MW of DMAPP. 
Additional characteristic fragment ions at m/z = 159.0 [M - H]- and m/z = 79.0 [M - H]- 
were confirmed. The MS2-fragmentation pattern (Figure 15) agrees with the previously 
reported data 111,112. 
 
 
Figure 15. Mass spectrometry of DMAPP. EPI-MS2 of m/z 245.0. 
 
3.1.2. Synthesis of PIBP, PIVP, and 2-MBP 
Plant-derived aromatic PTs are reported to accept a number of aromatic derivatives, 
such as phloroglucinols, xanthones, benzophenones, flavonoids and phenolic acids 
(Figure 11, page 43) 28,118. Since the biosynthesis of hyperforin and congeners (e.g. 
adhyperforin) in Hypericum was the focus of the current study, cores of these 
molecules were targeted for chemical synthesis. Due to the lack of cost-effective 
commercial sources, chemical synthesis was required to provide reliable prenyl 
acceptors for the activity screening of potential PTs.  
Phlorisobutyrophenone (PIBP) and 2-methylbutyrophenone (2-MBP) are the 
biosynthetic precursors of hyperforin and adhyperforin, respectively. Recently, auxin-
induced root cultures of H. peforatum were reported to accumulate colupulone, whose 
precursor is PIBP. Colupulone and lupulone are known as β-acids, which are 
characteristic of the hop female flower (Humulus lupulus). To cover the latter aspect, 
phlorisovalerophenone (PIVP) was chemically synthesized and included in the activity 
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assays, speculating on a side activity for a PIVP-accepting PT. Except for 2-MBP, 
which was synthesized according to Forbofou et al. (2016), PIBP and PIVP were 
synthesized as described by George et al. (2010). A Friedel-Craft reaction using 
phloroglucinol and either isobutyryl-chloride or isovaleryl-chloride was used for the 
synthesis of PIBP and PIVP, respectively. The synthesis of 2-MBP was done in two 
steps. Firstly, the synthesis of the alkyl-halide (S)-2-methylbutanoic chloride and 
secondly the Friedel-Craft reaction as described above for the formation of 2-MBP. 
Worthy to say that a racemic mixture of 2-MBP did not end in an enzymatically 
accepted product. Purification via semi-preparative HPLC was performed for all prenyl 
acceptors, which was preceded by column chromatography only in the case of PIBP 
(section 2.10.2., page 49).  
The molecular ion peaks [M + H]+ of all three products were further analyzed by MS2-
spectrometry (section 2.11.5., page 55). The molecular ions [M + H]+ of PIBP (m/z = 
197), PIVP (m/z = 211) and 2-MBP (m/z = 211) are shown in Figure 16 (A-C). They 
correspond to the MW of PIBP (196 g/mol), PIVP (210 g/mol) and 2-MBP (210 g/mol), 
as described in the literature (Li et al., 2015). All samples were additionally analyzed 
via 1H-NMR and 13C-NMR (Appendix 6.7. NMR Data, page 143).  
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Figure 16. MS2 Fragmentation pattern of (A) PIBP (m/z = 197.0), (B) PIVP (m/z = 211.0) and (C) 2-MBP 
(m/z = 211.1). The analysis was carried out in the positive ion mode (EPI+). 
 
3.1.3. Synthesis of 3-geranyl acylphloroglucinols 
In section 2.10.2, page 49, the chemical synthesis of the hyperforin skeleton, PIBP, 
was described. A cascade of 4–5 enzymes are required for the total hyperforin 
biosynthesis 28. Each enzymatic intermediate related to the hyperforin biosynthesis 
must therefore be considered as a potential PT substrate. Based on the results 
obtained in section 3.3.4., page 79, HpPT6 has been identified to accept exclusively 
3-geranyl-acylphloroglucinol derivates as substrates. All major substrates accepted by 
HpPT2, namely PIBP, PIVP, PAP, PBP and 2-MBP (section 3.3.4.4., page 82) have 
been chosen to synthesize as its 3-geranylated derivatives, as described previously 
116. Briefly, a mixture consisting of 1 molar equivalent acylphloroglucinol derivative 
(PIBP, PAP, PBP, 2-MBP or PIVP), 1 molar equivalent of geranyl bromide and 2 molar 
equivalents of K2CO3 were stirred at RT for 24 h under reflux. The products were 
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extracted and purified via semi-preparative HPLC (section 2.11.2., page 55). Structure 
verification was carried out by mass spectrometry and NMR spectroscopy.  
All five molecular-ion peaks [M + H]+ were further analyzed by MS2 spectrometry 
(section 2.11.5., page 55). The molecular ion [M + H]+ of 3-geranyl-PIBP (m/z = 333.2), 
3-geranyl-PAP (m/z = 305.0), 3-geranyl-PIVP (m/z = 347.5), 3-geranyl-PBP (m/z = 
367.1) and 3-geranyl-2-MBP (m/z = 345.4) are shown in Figure 17 (A-E) and 
correspond to the MW of 3-geranyl-PIBP (332 g/mol), 3-geranyl-PAP (304 g/mol), 3-
geranyl-PIVP (347 g/mol), 3-geranyl-PBP (366 g/mol) and 3-geranyl-2-MBP (344 
g/mol), respectively. Structure elucidation was additionally confirmed via 13C-NMR and 
1H-NMR analyses (section 6.7. NMR Data, page 143). 
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Figure 17.  MS2-Fragmentation patterns of chemically synthesized monogeranylated (MG) 
acylphlorogucinols, namely 3-geranyl-PIBP (A), 3-geranyl-PAP (B), 3-geranyl-PBP (C), 3-geranyl-PIVP 
(D) and 3-geranyl-2-MBP (E). Analyses were carried out in positive ion mode (EPI+). 
 
 
3.2. Biosynthesis of the hyperforin skeleton PIBP 
3.2.1. Activity assay of episomally expressed HpIBCL  
The results in this paragraph were produced in collaboration with Dr. Benye Liu who 
performed the enzymatic assay. The collaboration on product purification and analysis 
also involved Dr. Till Beuerle.   
The formation of the hyperforin core structure, PIBP, starts by the condensation of 
three molecules of malonyl-CoA and one molecule of isobutyryl-CoA 24. Consequently, 
the occurrence of isobutyryl-CoA in proper amounts is a prerequisite for in vivo 
production systems. Due to low availability of intracellular isobutyryl-CoA in yeast, an 
alternative approach was focused. Dr. Benye Liu cloned a cDNA for isobutyrate-CoA 
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ligase from H. perforatum, which forms isobutyryl-CoA from isobutyric acid and CoA in 
the presence of ATP. The cDNA was expressed in E. coli and the resulting protein was 
tested for in vitro activity. The product formed was purified and analyzed by mass 
spectrometry. The molecular ion peak [M - H]- with the m/z ratio of 836.6 (Figure 18, 
A) has been further analyzed by MS2 spectrometry and additionally compared with 
commercially available isobutyryl-CoA (Figure 18, B). The MW of the enzymatic 
product corresponded to the MW of isobutyryl-CoA (836.3 g/mol). The same 
fragmentation patterns were observed by comparing the enzymatic product with the 
reference compound (Figure 18, A and B).    
 
Figure 18. MS2 Fragmentation patterns of (A) the HpIBCL product isobutyryl-CoA (m/z = 836.3) and (B) 
the isobutyryl-CoA reference (m/z = 836.3.0). Analyses were carried out in negative ion mode (EPI-). 
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3.2.2. Expression of HpIBS in S. cerevisiae 
Based on the positive findings described in the previous paragraph, the subsequent 
step was the in vivo formation of PIBP. This was carried out by a type III polyketide 
synthase (isobutyrophenone synthase, IBS) performing the condensation of malonyl-
CoA and isobutyryl-CoA. Since a large number of PKSs were already omnipresent in 
our lab, Dr. Benye Liu provided an HpIBS with its known function as described above. 
The coding sequence was first heterologously expressed in E. coli and purified via Ni-
NTA agarose in collaboration with the Bachelor student David Quast 109. After 
successful activity evidence, the HpIBS (plus HIS6-tag) was cloned into the pESC-URA 
vector for the expression in S. cerevisiae. However, all trials failed to detect any 
enzymatic activity (Figure 19, A and B). Different variations have been investigated to 
overcome the bottleneck, such as varying incubation time, temperature, medium, and 
inducer concentration (galactose). Surprisingly, heterologous expression of a non-
tagged protein finally showed the expected activity. Enzymatic assay optimization was 
carried out in collaboration with the Bachelor student Henning Ummethum (Figure 19, 
C and D) 110. UV spectrum of the enzymatic product (Figure 19, C) corresponded to 
that of the PIBP reference compound (Figure 19, E). All trials to produce an active 
6xHis-tagged protein were unsuccessful, even when the optimized assay conditions of 
the untagged protein was applied. 
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Figure 19. Activity assays of episomally expressed HpIBS in S. cerevisiae. (A) Activity assay of His6 
tagged HpIBS; (B) Corresponding negative control; (C) Activity assay of untagged HpIBS; (D) 
Corresponding negative control; (E) PIBP reference compound. 
Results 
66 
 
3.2.3. Isobutyric acid toxicity test 
Yeast cells co-expressing HpIBCL and HpIBS were able to produce PIBP when 
isobutyric acid was supplied. To enable proper cultivation experiments, an isobutyric 
acid toxicity screening was performed. A yeast strain harboring the plasmid pESC-
URA_HpIBCL_HpIBS has been cultivated under different isobutyric acid 
concentrations. The Gal1/10 promoter was replaced by the two constitutive promoters 
pTEF1/pPGK1. This enables cultivation using sucrose as a carbon source for future 
experiments. A pre-culture was prepared in SGI-medium (Table 5, page 19) and the 
main culture was made in 10 mL YPSE-medium (Table 5, page 19) containing 0, 10, 
50 and 100 mM isobutyric acid. After 24 h of cultivation, new sterile sucrose (2 % final 
concentration) was added and growth continued for another 12 h. Finally, the yeast 
culture was harvested and the weight of the cell pellet was estimated (Table 31). The 
yeast cells were disrupted with glass beads and the enzymatic product was extracted 
twice with 10 mL ethyl acetate from both the cell pellet and the medium (10 mL).  
The following wet masses of the cell pellets were obtained as summarized in Table 31. 
For 0 mM (control), 0.2168 g were obtained, followed by 0.1557 g for 10 mM (72 %), 
0.1225 g for 50 mM (57 %) and finally 0.0107 g for 100 mM (5 %, i.e. ~ no growth).   
 
Table 31. Isobutyric acid toxicity effect on the yeast cultures* 
Isobutyric acid [mM] Pellet amount [g] 
Toxicity effect/growth 
inhibition [%] 
0 0.2168 0 
10 0.1557 28 
50 0.1225 43 
100 0.0107 95 
* Data from a single experiment 
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Control extract prepared from isobutyric acid-free cultures showed traces of the PIBP 
product (Figure 20, A and B). The medium extracted with ethyl acetate contained many 
impurities, which overlapped with the PIBP product peak (Figure 20, B). 
 
Figure 20. HPLC-DAD chromatograms of ethyl acetate extracts prepared from (A) cell pellet and (B) 
medium of a yeast culture episomally expressing HpIBCL and HpIBS. These cultures were grown on 
isobutyric acid-free medium. Arrow indicates the PIBP product peak. 
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In contrast, the PIBP product was readily detected in the pellet and medium extracts 
from a culture that was supplemented with 10 mM isobutyric acid (Figure 21). The 
amount of cell mass decreased by about 28 % (Table 12, page 24) compared to the 
control culture. The PIBP yield obtained was 1.15 µg/g fresh weight of the cell pellet 
and 0.059 µg/ml culture medium. Practically, it was impossible to calculate the absolute 
PIBP product amount due to the large extent of impurities, especially in the medium. 
 
Figure 21. HPLC-DAD chromatograms of ethyl acetate extracts prepared from (A) cell pellet and (B) 
medium of a yeast culture episomally expressing HpIBCL and HpIBS. The cultures were supplemented 
with 10 mM isobutyric acid. 
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The cell mass of the culture fed with 50 mM isobutyric acid was about 43 % less than 
the control culture, indicating an increasing toxicity level. The PIBP yield was 0.15 µg/g 
fresh weight of the cell pellet and 0.013 µg/ml culture medium.  
 
Figure 22. HPLC-DAD chromatograms of ethyl acetate extracts prepared from (A) cell pellet and (B) 
medium of a yeast culture episomally expressing HpIBCL and HpIBS. The cultures were supplemented 
with 50 mM isobutyric acid. 
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The ethyl acetate extract from the culture medium supplied with 100 mM isobutyric 
acid contained no PIBP peak at all (Figure 23). Only 5 % of the cell mass compared to 
the control was reached, which can be considered as no growth. This clearly indicates 
a toxicity potential, leading to cell death using isobutyric acid at 100 mM. Since the 
yeast cells did not grow anymore, the medium was not tested for product formation.   
 
Figure 23. HPLC-DAD chromatogram of an ethyl acetate extract prepared from the cell pellet of a yeast 
culture episomally expressing HpIBCL and HpIBS. The culture was supplemented with 100 mM 
isobutyric acid. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 
71 
 
The PIBP product from the culture supplemented with 10 mM isobutyric acid (pellet 
and medium) was HPLC purified and further analyzed by MS2 spectrometry (section 
2.11.5, page 55). The molecular ion peaks [M - H]- of pellet (Figure 24, A) and medium 
(Figure 24, B) show m/z = 195, which corresponds to the m/z of the reference PIBP 
(Figure 24, C). The same fragmentation patterns were observed for the PIBP products 
from the cell pellet (Figure 24, A) and the medium (Figure 24, B), compared to that of 
the reference PIBP (Figure 24, C).  
 
Figure 24. ESI-MS2 of PIBP purified from yeast cultures episomally co-expressing HpIBCL and HpIBS 
after feeding with 10 mM isobutyric acid. Analyses were carried out in negative ion mode (EPI-). 
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Another control was conducted by using the enzymatically formed PIBP as a substrate 
for HpPT2 in the presence of GPP. As shown in Figure 25 the enzymatic PIBP product 
was accepted by HpPT2 forming 3-geranyl-PIBP. PIBP was co-eluted with impurities 
in the purification step, as shown at a retention time between 7–8 min.  
 
 
Figure 25. HPLC-DAD analysis of an HpPT2 assay, in which the HpIBCL_HpIBS enzymatic product 
served as the substrate.  
 
 
3.2.4. Large scale cultivation of HpIBCL_HpIBS yeast (DASGIP®) 
The yeast strain containing HpIBCL and HpIBS sequences either episomally or 
genome integrated was cultivated at 250 mL scale using the DASGIP® bioreactors. 
The yeast strains used during this study did not contain any antibiotic-based selection 
markers. Therefore, the SGI-selection medium was used to maintain a selection 
pressure during the cultivation experiments to reduce a potential contamination risk. 
However, no PIBP product was detected in all experiments. This is most probably due 
to the selection of the wrong medium (SGI), because the PIBP product was detectable 
in YPGE and YPD media, respectively.  
 
 
3.3. Activity screening of Hypericum perforatum prenyltransferases 
In total, 12 different PT sequences were cloned in our group and provided for this 
project 111,112. The obtained PTs were cloned as both full-length and truncated versions 
into the pESC-URA expression vector. All 24 PT sequences were expressed in S. 
cerevisiae (section 2.8.2.4., page 37). The cells were disrupted and investigated for 
PT activity. The screening experiments were carried out using yeast crude protein 
extract (section 2.9.2.1., page 41) and a number of potential aromatic substrates 
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(Figure 11, page 43) as well as DMAPP and GPP as isoprenoid donors. The results 
obtained are summarized in Table 32. In this current study, only the yeast expression 
system was used for activity screening. No activities were found for HcPT1-3, HpPT3, 
HpPT4, HpPT7, and HpPT9. However, HpPT1, HpPT2, HpPT5, HpPT6, and HpPT8 
were active (Table 32, page 73). No dramatic differences were observed in the 
activities detected after heterologous expression of full-length or truncated proteins. 
Previously, an insect expression system was able to confirm additionally the activities 
for HcPT1 to HcPT3 112. The active PTs identified in this study can be divided into 
xanthone- and acylphloroglucinol-specific PTs. The enzymes HpPT1, HpPT5, and 
HpPT8 were found to be xanthone-specific (section 3.3.1., page 74 and section 3.3.2., 
page 76), whereas HpPT2 and HpPT6 were acylphloroglucinol-specific. The latter two 
enzymes offer potential candidates for assembling the hyperforin biosynthesis in yeast. 
Thus, they were subjected to experiments to explore the optimum incubation 
conditions and enzyme kinetics (section 2.9.2.1. page 41 and section 2.9.2.4., page 
44).     
 
Table 32. PT activities detected 
Enzyme  Active  Accepted substrates Co-substrate 
HcPT1 no - - 
HcTP2 no - - 
HcPT3 no - - 
HpPT1 yes 1,3,6,7-tetrahydroxyxanthone DMAPP 
HpPT2 yes PIBP, PAP, PBP, PIVP, 2MBP GPP 
HpPT3 no - - 
HpPT4 no - - 
HpPT5 yes 1,3,7-trihydroxyxanthone DMAPP/GPP 
HpPT6 yes 
3-G-PIBP*, 3-G-PAP*, 3-G-PBP*, 3-G-PIVP*,        
3-G-2MBP* 
DMAPP 
HpPT7 no - - 
HpPT8 yes 1,3,6,7-tetrahydroxyxanthone DMAPP 
HpPT9 no - - 
* 3-G = 3-Geranyl 
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3.3.1.  Enzymatic activity of HpPT5 
The xanthone-specific PT HpPT5 was cloned in collaboration with the Master student 
Svenja Patz119. The assay conditions were optimized using a “Design of Experiments” 
approach (Software: Modde), undertaken in collaboration with the internship students 
Sandra Grünhoff and Karna Meyer. 
The HpPT5 assay was carried out under the conditions described above (section 
2.9.2.1., page 41). The enzyme was found to accept 1,3,7-trihydroxyxanthone as the 
major acceptor substrate (synthesized by Dr. Gaid) and DMAPP and GPP as prenyl-
donors (Figure 26, C and E). The HpPT5 products, i.e. monoprenylated and 
monogeranylated 1,3,7-trihydroxyxanthones, were HPLC-purified and further analyzed 
by MS2-spectrometry (section 2.11.5., page 55). No product was detected in the control 
incubations containing either denatured protein or EDTA (100 mM) (Figure 26, A and 
B). 
The molecular-ion peak [M - H]- with m/z = 242.9 (Figure 26, A and B) corresponded 
to the HpPT5 substrate 1,3,7-trihydroxyxanthone (MW = 244 g/mol). A molecular ion 
peak at m/z = 311.4 confirmed the monoprenylation by the transfer of one isoprene 
unit (m/z = 68 g/mol) (Figure 26, C and D).  
Using GPP instead of DMAPP as a co-substrate, a molecular ion peak at m/z = 379.0 
confirmed the monogeranylation by the transfer of one geranyl unit (m/z = 136 g/mol) 
(Figure 26, E and F). Due to time limitation, it was not possible to produce a proper 
amount of the enzymatic products for further NMR spectroscopy analyses.  
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Figure 26. HPLC-DAD and ESI-MS2 of HpPT5 activity assays. (A) HPLC-DAD chromatogram of HpPT5 
control incubation (EDTA) and (B) ESI-MS2 of the substrate 1,3,7-trihydroxyxanthone. (C) HPLC-DAD 
chromatogram of HpPT5 incubated with DMAPP and (D) ESI-MS2 of the product monoprenyl-1,3,7-
trihydroxyxanthone. (E) HPLC-DAD chromatogram of HpPT5 incubated with GPP and (F) ESI-MS2 of 
the product monogeranyl-1,3,7-trihydroxyxanthone. MP and MG stand for monoprenylated and 
monogeranylated, respectively. 
 
 
3.3.1.1.  Localization of HpPT5 in S. cerevisiae  
Membrane-bound aromatic PTs are known to be localized in plants within the outer 
membranes of the chloroplast 88,120. However, yeast cells do not possess chloroplasts, 
therefore it was unknown to which membrane the PTs are finally targeted. HpPT5 was 
the first PT with an identified activity expressed in yeast during this study. Therefore, it 
was chosen for the localization experiment as an example PT. HpPT5 was cloned in 
frame with a C-terminal translational GFP fusion protein. The stop codon of HpPT5 
was removed by using a mutation primer to guarantee a continuous transcription of the 
cDNA. The obtained PCR fragment was cloned into a pESC-URA vector containing a 
GFP protein at the C-terminal end. Yeast cells containing the HpPT5_GFP fusion 
protein were cultivated under standard conditions (section 2.8.2.4., page 2.9.2.1.) and 
used for confocal microscopic screenings in collaboration with Dr. David Kaufholdt 
(Prof. Dr. Robert Hänsch group, Institute of Plant Biology, TU-Braunschweig). 
The intracellular fluorescence was evenly distributed over the cytoplasm of the cells 
but absent from the nucleus (Figure 27, A and C). This localization differed from the 
expression of the GFP protein only, which was also present in the nucleus due to its 
small size and solubility (section 3.3.3., page 78). These results agreed with the GFP 
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fluorescence detection in the insect expression system 112. In conclusion, the fusion 
protein in yeast cells may be localized to any organelle containing membranes, such 
as endoplasmatic reticulum, Golgi, and mitochondria. Another possibility might be the 
formation of evenly distributed inclusion bodies within the cytoplasm due to incorrect 
folding of the protein.   
Regarding the activity of the enzyme, no activity was detected when the HpPT5_GFP 
protein was incubated with 1,3,7-trihydroxyxanthone, which was opposite to the GFP-
free protein.  
 
 
Figure 27. Confocal laser scanning microscopy of S. cerevisiae expressing the HpPT5_GFP fusion 
protein at different magnification scales. N = nucleus.  
 
 
3.3.2. Enzymatic activity of HpPT8 
HpPT8 assays were carried out as described above (section 2.9.2.1, page 41). HpPT8 
was found to accept 1,3,6,7-tetrahydroxyxanthone as the major acceptor molecule and 
only DMAPP as prenyl donor (Figure 28, C and E). The HpPT8 product was HPLC 
purified and further analyzed by MS2-spectrometry (section 2.11.5., page 55). No 
product was detected in the control incubation containing either denatured protein or 
EDTA (100 mM) (Figure 28, A and B).  
The molecular ion peak [M - H]- of the HpPT8 substrate 1,3,6,7-tetrahydroxyxanthone 
(MW = 260 g/mol) appears at m/z = 259.3 (Figure 28, B). The HpPT8 product peak 
resulting from incubation with DMAPP (Figure 28, C) showed m/z = 327.3 (Figure 28, 
D), which corresponded to the addition of one prenyl group (MW = 68 g/mol) to the 
substrate.  
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No further product formation was observed using GPP instead of DMAPP as a co-
substrate (Figure 28, E). Due to time limitation, it was not possible to produce enough 
enzymatic product for further NMR spectroscopy analysis.  
 
 
Figure 28. HPLC-DAD and ESI-MS2 of HpPT8 activity assays. (A) HPLC-DAD chromatogram of HpPT8 
control incubation (EDTA) and (B) ESI-MS2 of the substrate 1,3,6,7-tetrahydroxyxanthone. (C) HPLC-
DAD chromatogram of HpPT8 incubated with DMAPP and (D) ESI-MS2 of the product monoprenyl-
1,3,6,7-tetrahydroxyxanthone. (E) HPLC-DAD chromatogram of HpPT8 incubated with GPP. 
MP_1,3,6,7-tetrahydroxyxanthone stands for monoprenylated 1,3,7-trihydroxyxanthone. 
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3.3.3. Carbon source improvement for the pESC-URA expression system 
To investigate the effect of different carbon sources on the protein expression level, 
four different carbon sources (glucose, sucrose, raffinose, and glycerol) were tested. 
The Gal1/10 promoter present in the pESC-URA expression vector is repressed in the 
presence of glucose. Therefore, the GFP coding sequence was cloned into the pESC-
URA vector and expressed under standard conditions (section 2.8.2.4., page 37). 
Glucose, glycerol, raffinose and sucrose were used at a final concentration of 2 % for 
the main culture. Galactose was used as protein expression inducer after 24 h of 
cultivation. The GFP protein expression level with glucose was markedly lower (Figure 
29, A), compared to that in the culture supplemented with sucrose (Figure 29, B and 
C). The fluorescence was evenly spread over cytoplasm and nucleus. The growth rates 
using glycerol and raffinose were lower compared to glucose and sucrose. Notably, 
raffinose is more expensive (>1 € / 1 g) and was therefore not furthermore considered 
as a cost-effective carbon source.       
 
 
Figure 29. Confocal laser scanning microscopy of S. cerevisiae expressing GFP protein under use of 
different carbon sources (A) glucose; (B, C) sucrose at different magnification scales. 
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3.3.4. Biochemical investigation of acylphloroglucinol-specific HpPT2 
 
3.3.4.1. Incubation time and protein dependency 
The linearity of the enzyme activity with respect to incubation time and protein amount 
is an important aspect for the further kinetic study. For kinetic characterization, 
appropriate enzyme concentrations and incubation times must be selected to achieve 
linear reaction velocity during the assay period. Extended incubation times will lead to 
false measurements due to the gradual slowing in the reaction velocity and potential 
instability of the end product. High protein amounts might have inhibitory effects 
leading to inaccurate measurements. These experiments were carried out under 
standard conditions (section 2.9.2.2., page 44), except for varying the incubation time 
and protein amount from 2 -120 min and 10 - 1200 µg, respectively. 
The HpPT2 activity was linear up to 15 min reaching a plateau from 20 min to 40 min. 
After 60 min of incubation, the 3-geranyl-PIBP product amount started to decrease due 
to degradation effects (Figure 30, A).  
The incubation time of 10 min was selected to investigate the protein dependency. A 
linear enzyme activity was analyzed up to 400 µg protein whereas the maximum 
product formation was observed at 1000 µg of microsomal fraction (Figure 30, B).  
 
 
Figure 30. The linearity of HpPT2 activity with (A) incubation time and (B) protein amount. The results 
are means ± SD from three independent experiments. 
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3.3.4.2. Effect of divalent cations 
Different classes of enzymes are dependent on co-factors such as divalent cations. 
Aromatic PTs are divalent cation dependent and require mainly Mg2+, Ca2+, Fe2+ or 
Mn2+ to perform the biochemical reactions 75. The effect of divalent cations was 
investigated under standard assay conditions (section 2.9.2.2., page 44), except for 
varying the type of the divalent cation. The concentration of each divalent cation was 
constant at 10 mM for all incubation reactions.  
The most preferred cation was found to be Mg2+ for HpPT2. Comparing the relative 
activity of other cations tested, the following activities were detected: Ca2+ = 16 %, Fe2+ 
= 15 %, Zn2+ = 13 %, Co2+ = 8 %, Mn2+ = 3 %, and Cu2+ = no activity. No activity was 
observed when metal ions were chelated using EDTA, indicating the absolute 
dependency on divalent cations (Figure 31).     
 
 
Figure 31. Effect of divalent cations on HpPT2 enzymatic activity. The results are means ± SD from 
three independent experiments. 
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3.3.4.3. Effect of incubation temperature and pH 
The temperature and pH are critical parameters influencing the activity of enzymes. 
The pH has a large influence on the overall protein charge and therefore on the tertiary 
structure. The temperature has an influence on the reaction velocity of the enzyme 
itself. Temperature and pH values far away from the natural environment can cause 
improper folding and/or inactivation of the enzyme.  
The experiments were carried out under standard conditions (section 2.9.2.2., page 
44), except for varying the temperature and pH from 20 - 80 °C and the pH from 5 – 
10. The temperature and pH optima were identified to be 40 °C and 7–8, respectively 
(Figure 32, A and B). The enzymatic activity started to decrease when the temperature 
was higher or lower than 40 °C. In addition, pH ranges below or above 7 – 8 negatively 
affected the enzymatic activity by about 50 % (Figure 32, B).  
  
 
 
Figure 32. The dependency of HpPT2 activity on incubation conditions. (A) Effect of incubation 
temperature. (B) Effect of incubation pH. The results are means ± SD from three independent 
experiments. 
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3.3.4.4. Substrate specificity of HpPT2 
Most enzymes accept a series of closely related substrates with varying preference. 
To determine which substrates are accepted and which are preferred, HpPT2 was 
incubated with a series of different aromatic substrates (Figure 11, page 43) under 
standard conditions (section 2.9.2.2., page 44).   
HpPT2 was identified to be highly specific for acylphloroglucinol derivates. No activity 
was observed with other aromatic compounds, e.g. xanthones. The acylphloroglucinol 
derivative PIBP was the preferred substrate (100 %). PIBP, 2-MBP, 2,3',4,6-
tetrahydroxybenzophone, PAP, PIVP, and PBP were also accepted but at lower 
relative activities of 70.6, 31.7, 16.9, 16.3, and 5 %, respectively (Figure 33, page 82).     
 
Figure 33. Substrate specificity of HpPT2. The results are means ± SD from three independent 
experiments. 
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3.3.4.5. Determination of kinetic parameters for HpPT2 
The determination of the kinetic parameters for HpPT2 was carried out for the two 
preferred substrates, i.e. PIBP and 2-MBP (section 3.3.4.4., page 82).  
The apparent KM values were determined by varying the PIBP or 2-MBP 
concentrations, while keeping the GPP concentration saturating and constant. The 
apparent KM value for GPP was determined by using varying GPP concentrations while 
keeping PIBP and 2-MBP at saturating constant concentration. All measurements were 
done by three technical replicates (section 2.9.2.2., page 44).  
The best substrate affinity was observed for 2-MBP with KM = 85 ± 15 µM (Vmax = 5.1-
3 ± 5-4 nmol/mg microsomal protein/min), followed by PIBP with KM = 124 ± 19 µM (Vmax 
= 8.0-3 ± 9-5 nmol/mg microsomal protein/min). The apparent KM value for GPP2-MBP 
was 60 ± 11 µM (Vmax = 4.6-3 ± 3-4 nmol/mg microsomal protein/min) and that for 
GPPPIBP was 89 µM ± 35 (Vmax = 7.1-3 ± 9-4 nmol/mg microsomal protein/min), as 
summarized in Table 33. Data presented are the means of three technical replicates. 
 
Table 33. Kinetic parameters of HpPT2 
Substrate  KM [µM]* 
Vmax  
[nmol/mg microsomal protein/min]* 
2-MBP   85 ± 15 5.1-3 ± 5-4 
PIBP 124 ± 19 8.0-3 ± 9-5 
GPP2-MBP   60 ± 11 4.6-3 ± 3-4 
GPPPIBP   89 ± 35     7.1-3 ± 9-4 
*The results are means ± SD from three independent experiments. 
 
3.3.4.6. Structure elucidation of HpPT2-formed 3-geranyl-PIBP 
HpPT2 was found to prefer PIBP as acceptor substrate and GPP as geranyl donor 
(Figure 34 (C, D), page 84). No product was detected in the control incubation 
containing either denatured protein or EDTA (Figure 34, A and B). The molecular-ion 
peak [M + H]+ of the HpPT2 substrate PIBP (MW = 196 g/mol) is at m/z = 197.0 (Figure 
34, B). The HpPT2 product peak (Figure 34, C) is at m/z = 333.2 (Figure 34, D), which 
corresponds to the addition of one geranyl group (MW = 136 g/mol) to the substrate. 
Chemically synthesized 3-geranyl-PIBP was structurally confirmed by MS2 
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spectrometry (section 2.11.5., page 51). The retention time, UV-spectrum and 
fragmentation pattern of the HpPT2 product using PIBP as substrate matched the data 
obtained for the authentic reference 3-geranyl-PIBP (Figure 34, C-F). Authentic 3-
geranyl-PIBP was then used as a substrate for HpPT6 (section 2.9.2.4., page 44). 
 
Figure 34. HPLC-DAD and ESI-MS2 of HpPT2 activity assays. (A) HPLC-DAD chromatogram of HpPT2 
control incubation (EDTA) and (B) ESI-MS2 of the substrate PIBP. (C) HPLC-DAD chromatogram of 
HpPT2 incubated with GPP and (D) ESI-MS2 of the product 3-geranyl-PIBP. (E) HPLC-DAD 
chromatogram of 3-geranyl-PIBP as a reference and (F) ESI-MS2 of 3-geranyl-PIBP.  
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3.3.5. Biochemical investigation of acylphloroglucinol-specific HpPT6 
 
3.3.5.1. Incubation time and protein dependency 
These experiments were carried out under standard conditions (section 2.9.2.3., page 
44), except for varying the incubation time and protein amount from 2-120 min and 10 
- 1600 µg, respectively. Product detection and quantification were performed by HPLC-
DAD analysis using a calibration curve (section 2.11.2., page 53).  
A linear dependency of the incubation time was detected up to 15 min. After 15 min, 
the rate of product formation became lower reaching a plateau from 30 to 60 min. A 
severe degradation of the 5-prenyl-3-geranyl-PIBP product started after 60 min of 
incubation time (Figure 35, A). A linear dependency was detected up to 800 µg 
microsomal protein with subsequently reaching a plateau at around 1500 µg (Figure 
35, B).   
 
Figure 35. The dependency of HpPT6 on A) incubation time and B) protein amount. The results are 
means ± SD from three independent experiments. 
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3.3.5.2. Effect of divalent cations 
These experiments were carried out under standard conditions as described (section 
2.9.2.3., page 44), except for varying the divalent cations. The concentration of each 
divalent cation was constant at 10 mM in all incubation reactions.  
For HpPT6, the divalent cation Ca2+ was identified to be the most preferred metal 
cation. Comparing the relative activities of other cations tested, the second preferred 
cation was Mn2+, followed by Mg2+, and Fe2+ with 64, 37 and 19% activities relative to 
that detected in the presence of Ca+2. No activities were detected with Co2+, Mn2+ and 
Cu2+. EDTA (10 mM) abolished the enzymatic activity, indicating a clear dependency 
on a divalent cation (Figure 36).   
 
 
Figure 36. The dependency of HpPT6 activity on divalent cations. The results are means ± SD from 
three independent experiments. 
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3.3.5.3. Effect of incubation temperature and pH 
The experiments were carried out under standard conditions (section 2.9.2.3., page 
44), except for varying the temperature from 20-80 °C and the pH from 5-10. The 
temperature and pH optima were identified to be at 50 °C and pH 8–9, respectively 
(Figure 37, A). The enzymatic activity started to decrease when the temperature was 
higher or lower than 50 °C. Furthermore, pH ranges below or above 7–9 decreased 
the activity by about 40 % (pH 7) and 20 % (pH 10) (Figure 37, B). 
 
 
Figure 37. The dependency of HpPT6 on incubation temperature (A)  and pH (B). The results are means 
± SD from three independent experiments. 
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3.3.5.4. Substrate specificity of HpPT6 
HpPT6 was identified as highly specific for 3-geranyl-acylphloroglucinol derivates. The 
substrate 3-geranyl-PIVP was the preferred one (100 %), followed by 3-G-2-MBP, 3-
G-PIBP, 3-G-PBP and 3-G-PAP (Figure 38), which were accepted with relative 
activities of 91, 90, 32 and 28 %, respectively. 
 
 
Figure 38. Substrate specificity of HpPT6. The results are means ± SD from three independent 
experiments. 
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3.3.5.5. Determination of kinetic parameters for HpPT6  
The determination of the kinetic parameters for HpPT6 was carried out for the three 
best accepted substrates, namely 3-G-PIVP, 3-G-2MBP and 3-G-PIBP (section 
3.3.5.4., page 88).  
The apparent KM values were determined by using varying acceptor concentrations 
while keeping the DMAPP concentration constant at saturation. The apparent KM value 
for DMAPP was determined by using varying DMAPP concentrations while keeping 
the acceptor substrate at a constant saturating concentration. All measurements were 
done as three technical replicates (section 2.9.2.3., page 44).  
The apparent KM value for 3-G-PIVP was 78 ± 8.6 µM (Vmax = 1.1-3 ± 4-4 nmol/mg 
microsomal protein/min), that for 3-G-2MBP was 73 ± 10 µM (Vmax = 8.2-4 ± 8-4 nmol/mg 
microsomal protein/min) and that for 3-G-PIBP was 181 ± 218* µM (Vmax = 5.8-4 ± 3-4 
nmol/mg microsomal protein/min). The apparent KM value for GPP3-G-PIVP was 185 ± 12 
µM (Vmax = 1.3-3 ± 6-5 nmol/mg microsomal protein/min), that for GPP3-G-2-MBP was 100 
± 18 µM (Vmax = 9.1-4 ± 9-5 nmol/mg microsomal protein/min), and that for GPP3-G-PIBP 
was 141 ± 17 µM (Vmax = 8.7-4 ± 7-5 nmol/mg microsomal protein/min). Data presented 
are the means of three technical replicates. 
  
Table 34. Kinetic parameters determined for HpPT6 
Substrate  KM [µM]* 
Vmax  
[nmol/mg microsomal protein/min]* 
3-G-PIVP 78 ± 8.6 1.10-3 ± 4-4 
3-G-2-MBP 73 ± 10** 0.80-3 ± 8-4 
3-G-PIBP 181 ± 218 5.8-4 ± 3-4 
DMAPP3-G-PIVP 185 ± 12 1.30-3 ± 6-5 
DMAPP3-G-2-MBP 100 ± 18 0.91-3 ± 9-5 
DMAPP3-G-PIBP 141 ± 17 0.87-3 ± 7-5 
*The results are means ± SD from three independent experiments. **Value is a mean of two replicates. 
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3.3.5.6. Structure elucidation the HpPT6 product 
HpPT6 was found to accept the HpPT2 product 3-G-PIBP as prenyl acceptor substrate 
and DMAPP as prenyl donor substrate (Figure 39, C and D). No product was detected 
in the control incubation containing either denatured protein or EDTA (Figure 39, A and 
B). The molecular-ion peak [M + H]+ of the HpPT6 substrate 3-G-PIBP (MW= 332 
g/mol) was at m/z = 333.2 (Figure 39, B). The HpPT6 product peak (Figure 39, C) 
appeared at m/z = 401.2 (Figure 39, D), which corresponded to the addition of one 
prenyl-group (MW = 68 g/mol) to the substrate. Due to the instability of 3-geranyl-5-
prenyl-PIBP, it was not possible to synthesize a reference compound. Chemically 
synthesized polyprenylated phloroglucinol derivatives were spontaneously degraded, 
hindering further structural elucidation. Only the non-prenylated and mono-geranylated 
compounds were stable for long time periods.  
 
Figure 39. The activity of HpPT6 using 3-G-PIBP as a substrate. (A, C) HPLC-DAD analysis of assays 
done with heat-denatured protein (A) and crude microsomal fraction (C). (B, D) ESI-MS2 of the substrate 
(B) and the enzymatic product 3-geranyl-5-prenyl-PIBP (D). 
 
 
3.3.6. Genome integration of HpIBCL_HpIBS, HpPT2, and HpPT6 
For the heterologous production of plant secondary metabolites in microbial hosts, a 
number of genes must be expressed to yield an enzyme cascade. Many laboratory 
organisms such as S. cerevisiae are limited to few antibiotics, which can be used for 
selection purposes. Therefore, the integration of heterologous genes into the genome 
with subsequent marker removal is a commonly used strategy 121. HpIBS and HpIBCL 
sequences were integrated into the genome and expressed (Figure 41, section 2.7.7., 
page 27). The product of the enzymes was extracted from 100 mL culture, purified by 
HPLC and further analyzed by MS2 spectrometry (Figure 40). Comparing its UV 
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spectrum upon HPLC-DAD analysis and its fragmentation pattern (Figure 40) with 
those of the PIBP reference (Figure 21, page 68) confirmed the formation of the correct 
product. Feeding 10 mM isobutyric acid after episomal expression of HpIBCL and 
HpIBS led to production of PIBP at levels of 1.15 ng/mg fresh weight cell pellet and 
59.2 ng/ml culture medium. However, the product amount obtained after integrating 
HpIBCL and HpIBS into the yeast genome was much lower than the corresponding 
episomal production and could not be calculated exactly.  
The PTs HpPT2 and HpPT6 were additionally integrated into the same yeast strain 
containing HpIBCL and HpIBS (Figure 41, section 2.7.7., page 27). The activity was 
tested by feeding the substrates isobutyric-acid or PIBP. Only traces of the HpPT2 
product could be detected by HPLC analysis (data not shown).       
 
Figure 40. HPLC-DAD (A) and ESI-MS2 (B) of PIBP (m/z = 195) purified from yeast cultures co-
expressing HpIBCL and HpIBS (genome integrated). The cultures were supplemented with 10 mM 
isobutyric acid. 
 
Figure 41. Integration of HpIBCL, HpIBS, HpPT2, and HpPT6 into the yeast genome, as indicated by 
PCR amplification of target sequences from genomic DNA and gel electrophoretic detection. 
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4. Discussion 
Basic research leads to an increasing fundamental knowledge, which is usable for 
human beings. One major research part is focused on medical progress enabling to 
cure or alleviate many diseases. Since thousands of years, our ancestors knew about 
the healing effects of plants without understanding the underlying mechanisms. 
Nowadays, human beings constantly recognize the advantages of using plant 
secondary metabolites as food additives (e.g. Golden Rice) or medicinal applications 
(e.g. antidepressants). The isolation of plant secondary metabolites is still very costly 
due to the downstream processing to remove chlorophyll and other undesired 
constituents. Multistep reactions, e.g. the synthesis of highly complex secondary 
metabolites such as hyperforin, are very time-consuming and costly due to low 
productivity. Therefore, the recombinant production of secondary metabolites is an 
alternative approach to provide larger amounts of plant secondary metabolites for 
clinical research and subsequent medical applications. To date, the full biosynthetic 
sequences of many valuable natural secondary metabolites are not well understood, 
which demands further basic research into this field. One of the most famous medicinal 
plants is H. perforatum. It contains the secondary metabolite hyperforin, which is 
responsible for the use of Hypericum extracts to treat mild to moderate depression. 
The chemical synthesis of hyperforin requires at least 10 steps, which is very laborious 
and expensive. Additionally, the yield of this chemical synthesis is very low 44–46. Thus, 
the focus of the present research was the investigation of enzymes involved in the 
biosynthesis of hyperforin.  
 
 
4.1. Carbon source optimization   
Engineering metabolic pathways requires, besides the coding sequence of target 
genes, the correct control of the protein expression. This should be optimized regarding 
the induction time, gene copy number and expression level. There are a number of 
inducible and constitutive promoters available for yeast expression systems 122–125. 
The most commonly used promoters are pGal1 and pGal10 for inducible expression 
and pTEF1 and pPGK1 for constitutive expression with varying expression strengths 
124. While pTEF1/pPGK1 work under glucose, the Gal1/10 promoters are activated by 
galactose and repressed in the presence of glucose 126. The latter expression system 
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was used for the recombinant expression of H. perforatum-derived PTs. To improve 
the PT expression level, different carbon sources were tested and compared with 
glucose as the standard carbon source. To have a test gene, the GFP cDNA was 
cloned into the pESC-URA expression vector. The yeast strain containing the GFP 
cDNA was cultivated using glycerol, sucrose, raffinose, and glucose. Utilizing glycerol 
has several advantages like it does not exert the Crabtree effect; it is a cheap waste 
product from fuel production and therefore does not interfere with the food industry 127–
129. However, the growth rate and biomass formation are lower compared to the other 
carbon sources used, which agreed with our findings 130. A possibility to overcome this 
bottleneck would be genetic engineering or evolutional engineering approaches 130–132. 
The advantage of using raffinose is that there is no repression or induction at all of the 
Gal1/10 promoter systems 133. The major disadvantage of using raffinose is the high 
cost (1 €/ 1 g). Therefore, glycerol and raffinose have been omitted as a useful carbon 
source from further experiments.  
S. cerevisiae itself possesses the enzyme invertase which converts sucrose into 
glucose and fructose, encoded by the SUC gene cluster 134. The monosaccharides 
(glucose and fructose) enter the cells and become available for glycolysis (Embden-
Meyerhof-Parnas glycolytic pathway), which guarantees proper growth 134. By 
comparing the GFP fluorescence using either glucose or sucrose, a much higher 
fluorescence was found with sucrose (Figure 29, page 78). This can be explained by 
the strong inhibition effects of glucose on the Gal1/10 promotors 135. Furthermore, 
sucrose was identified as a usable carbon source because of its higher cell mass 
formation and higher functional expression rate compared to glucose 122. 
During this study, we decided to use sucrose because it is very cost effective and the 
growth rate and biomass formation are higher than with glucose. Additionally, it can be 
used for gene expression using constitutive promoters, as done with HpIBCL and 
HpIBS.    
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4.2. Chemical synthesis of PT substrates 
Most enzymes require, besides the substrates, additional co-factors and co-substrates 
to perform the biosynthesis. Aromatic PTs catalyze the transfer of isoprenoid moieties, 
e.g. DMAPP, GPP, and FPP, to a variety of aromatic acceptors. Most aromatic and co-
substrates used in this study were either commercially unavailable and/or too 
expensive. Therefore, a number of substrates were chemically synthesized by our 
working group. 
 
Chemical synthesis of DMAPP 
Isoprenyl moieties, such as DMAPP (C5), GPP (C10) and FPP (C15), are the major co-
substrates utilized by the aromatic PTs. DMAPP for hyperforin biosynthesis is derived 
from the non-mevalonate pathway by isomerization of IPP catalyzed by isopentenyl 
diphosphate isomerase (IPPI). Subsequent geranyl diphosphate (GPP) synthase or 
farnesyl diphosphate (FPP) synthase condense DMAPP and IPP or GPP and IPP to 
form GPP and FPP, respectively 136. The aromatic PT cDNAs used in this study were 
cloned by Dr. Tobias Fiesel, Dr. Andreas Müller, and Dr. Mariam Gaid 111,112. To 
determine the active PTs and their substrate scope, DMAPP was synthesized in 
collaboration with Dr. Mariam Gaid, Dr. Eline Biedermann, and Mohamed Nagia. The 
synthesized DMAPP was validated by MS2 spectrometry and its properties were 
compared with the data of Dr. Andreas Müller and Dr. Tobias Fiesel 111,112. The 
molecular ion [M - H]-  was at m/z = 245.0, which corresponded to the molecular mass 
of 246 g/mol. The fragmentation pattern of DMAPP compared to that of DMAPP 
synthesized by Dr. Andreas Müller and Dr. Tobias Fiesel 111,112.  
 
 
Chemical synthesis of acylphloroglucinol derivatives 
Acylphloroglucinols are secondary metabolites occurring in various plant families such 
as Hypericaceae (e.g. H. perforatum) and Cannabinaceae (e.g. Humulus lupulus). 
These constituents are naturally derived from the polyketide pathway and their 
biosynthesis is catalyzed by type III polyketide synthases. Several acylphloroglucinol 
derivatives were required as PT substrates in this study. Since they are not 
commercially available, they were chemically synthesized. PIBP, 2-MBP, and PIVP 
represent the core skeletons of hyperforin, adhyperforin, and lupulone (hop β-bitter 
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acid), respectively. These compounds were used as substrates for HpPT2. All 
synthesized substrates were analyzed by MS2 spectrometry and NMR spectroscopy. 
Besides these synthesized compounds, further commercially available substrates 
were employed for enzymatic incubations with HpPT2. The major difference between 
the substrates is the residue (R-), i.e. the acyl moiety attached to the aromatic ring 
(Figure 42). The conformation and length of the acyl-side chain can influence the 
substrate specificity of the enzyme. Therefore, it was necessary to synthesize and test 
a large variety of potential substrates. 
In this study, HpPT2 was identified to transfer one geranyl side chain to substrates 
tested as described above. A second enzyme named HpPT6 was found to accept the 
enzymatic product of HpPT2 as a substrate. Therefore, it was also necessary to 
chemically synthesize the 3-geranyl-derivatives of the major HpPT2 substrates, 
namely PIBP, PAP, PBP, PIVP, and 2-MBP (Figure 42). The monogeranylated analogs 
served to characterize HpPT6.  
 
 
Figure 42. Chemically synthesized substrates for HpPT2 (without the 3-geranyl side chain) and HpPT6 
(with the 3-geranyl-side chain, red oval).   
  
 
4.3. Biosynthesis of the hyperforin core structure PIBP 
The recombinant production of plant secondary metabolites like hyperforin or precursor 
molecules such as PIBP requires the expression of enzymes involved in their 
biosynthesis. The hyperforin biosynthesis starts with the formation of the core structure 
PIBP. This is achieved in two major enzymatic reactions, involving a short chain fatty 
acyl-CoA ligase and a type III polyketide synthase 24.  
During this Ph.D. project, the first aim was to increase the intracellular isobutyryl-CoA 
concentration because of its low intracellular availability. Isobutyryl-CoA is present in 
S. cerevisiae as intermediate for the biosynthesis of isopropanol 137. For this, valine is 
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degraded by the branched-chain α-ketoacid dehydrogenase complex forming 
isobutyryl-CoA as intermediate 28,48,49,54,137,138. Based on transcriptomic data, a short 
chain fatty acyl-CoA ligase (isobutyryl-CoA ligase) from H. perforatum was cloned by 
Dr. Benye Liu using a previously cloned CoA ligase from H. lupulus as a blast template 
48. The HpIBCL cDNA was first expressed in E. coli to verify the activity and substrate 
specificity. The enzymatic product was isolated and analyzed by MS2 spectrometry, 
confirming the identity as isobutyryl-CoA in comparison to the commercially available 
reference. 
For yeast, to avoid ester purification and development of an enzymatic assay, which is 
difficult and time-consuming, we decided to perform an indirect activity test. This 
approach was carried out by cloning together the HpIBCL and HpIBS sequences with 
their known functions to form PIBP. Both genes were expressed under the constitutive 
promoters pTEF1/pPGK1, which enable the use of sucrose instead of glucose as 
carbon source. For the toxicity of isobutyric acid, a toxicity test was simultaneously 
performed once by testing different concentrations (10, 50, 100 mM). 
In the control culture without isobutyric acid supplementation, only traces of PIBP could 
be detected. This result confirmed the presence of intracellular isobutyric acid and 
isobutyryl-CoA derived from the degradation of valine by the branched-chain alpha-
keto complex, enabling the formation of PIBP just in the presence of HpIBS and 
HpIBCL 48. The amount of cell mass decreased (~ 28 %) at 10 mM isobutyric acid, 
whereas nearly no growth was detectable using 100 mM. These results clearly confirm 
the toxicity of isobutyric acid for cell growth when used as a substrate. This finding 
raises the question how to overcome the bottleneck for future large-scale or long-time 
cultivation experiments. There are two potential approaches, which may be useful to 
pave the way. One approach may be fed-batch cultivation experiments, enabling the 
continuous feeding of the substrate below the toxicity level. Another approach may be 
the adaptation of the yeast cells to grow on higher isobutyric acid concentrations, 
achievable by applying a microbial adaptive laboratory evolution (ALE) approach 
7,131,132,139. 
An approach similar to ours for the recombinant production of PIBP or PIVP in S. 
cerevisiae was achieved by the co-expression of Humulus lupulus (hop)-derived 
isobutyryl-CoA ligase or isovaleryl-CoA ligase together with a valerophenone synthase 
34. That is because acylphloroglucinols PIBP and PIVP are also precursors of 
cohumulone and humulone (hop bitter tast), respectively. By the co-expression of 
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isobutyryl-CoA ligase and valerophenone synthase, about 2.3 µM PIBP (0.4 µg/mL) 
was detected after 96 h of galactose induction without any precursor feeding. This 
indicates a clear evidence of the presence of isobutyric acid, which can be further 
converted to the starter acyl-CoA 34. This also agreed with our findings obtained in this 
study, as described previously. The PIBP product amount was increased by 
supplementing 2 mM valine to about 2.83 µM PIBP, pointing to the direct connection 
of valine degradation to isobutyryl-CoA 48,137. 
However, the recently published results 34 cannot be directly compared with the results 
obtained in this study. Both genes used here were expressed under a constitutive 
promoter to enable the cultivation on sucrose as carbon source. Furthermore, the PIBP 
product was isolated and quantified from the cell pellet due to fewer impurities 
compared to the medium. Additionally, the focus of this study was to increase the PIBP 
product yield by feeding isobutyric acid, circumventing the need of further intermediate 
degradation steps of valine.   
Additional experiments must be carried out to finally prove the involvement of these 
enzymes in the biosynthesis of hyperforin. These include the determination of kinetic 
parameters of HpIBCL and HpIBS compared to other IBLs and IBSs found in H. 
perforatum. Furthermore, the transcript levels for HpIBCL and HpIBS within the plant 
organs containing PIBP, hyperforin and closely related derivates should be 
investigated. This experiment includes fruits, flowers, and leaves and there should be 
a high abundance of highly similar sequences in all the transcriptomes. Additionally, 
all enzymes should show the same or comparable activity regarding their substrate 
specificity. In this study, no detailed information about the transcripts and enzymes was 
obtained. 
To summarize, the experiments described in this section must be considered as a proof 
of principle for the functional expression in yeast of HpIBCL and HpIBS derived from 
H. perforatum. It was possible in this study to express two consecutive enzymes to 
form the hyperforin precursor molecule PIBP (Figure 43). 
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Figure 43. Biosynthesis of the hyperforin core structure PIBP. 
 
 
4.4. Aromatic Prenyltransferases 
Aromatic PTs have already been isolated and biochemically characterized from 
species throughout different kingdoms of life such as fungi, bacteria and plants 12,74,75. 
They are involved in the biosynthesis of primary and secondary metabolites such as 
terpenoids and pigments, hormones etc. Plant-derived aromatic PTs are located in the 
envelope of plastids and transfer isoprenoid moieties to different aromatic compounds 
including xanthones, benzoic acid derivatives, (iso)flavonoids, coumarins, and 
phloroglucinol derivatives 34,77–95. The most abundant compounds carry dimethylallyl 
and geranyl side chains rather than farnesyl and geranylgeranyl residues 77. 
Prenylated compounds demonstrate a large variety of biological activities and are 
therefore promising high-potential candidates for future drug development 77. 
The PTs used in this study were isolated based on available transcriptomes of  H. 
perforatum and a subtracted cDNA library of H. calycinum, prepared in our working 
group 51. In total, three full-length cDNAs from H. calycinum and nine from H. 
perforatum were obtained based on the aspartate-rich motifs “NDxxDxxxD” and 
“KDxxDxxGD” 12,25,74,75. Both aspartate-rich motives are typically known for plant-
derived PTs, discovered and published by Prof. Kazufumi Yazaki 12. These motifs are 
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made responsible for substrate binding as well as chelating divalent cations such as 
Mg2+, Mn2+ etc, required to perform the catalytic reaction 75. Bacterial and fungi 
aromatic PTs lack the aspartate-rich motifs 75. Here, positively charged amino acids 
take over the function of the divalent cations to perform the catalytic reaction 140. 
Besides the mentioned different characters, there are two more major differences 
compared to bacterial and fungi-related PTs. The first divergence is the solubility of 
bacterial and fungal PTs. Second, they belong to the ABBA superfamily, members of 
which form an antiparallel β-sheet structure (αββα motif) and perform their catalytic 
reaction within the β-barrel. This structure also leads to a wider substrate specificity 
compared to plant-derived prenyltransferases 75. Plant PTs are located within the outer 
membranes of the plastids and possess typically several transmembrane domains. 
Therefore, these PTs are not soluble and proposed to perform their catalytic reaction 
on the exterior of the protein domains 75,141.   
The PTs tested in this study possess the usual plant-PT characteristics as described 
above. The PTs isolated by Dr. Tobias Fiesel have been bioinformatically defined to 
have between 5–9 transmembrane domains 112. Furthermore, all functionally 
expressed PTs were dependent on divalent cations and were membrane bound. All in 
vitro assays were performed with either insect (Sf9) or yeast microsomal fractions 112.  
Twelve PTs, three from H. calycinum (HcPT 1-3) and nine from H. perforatum (HpPT1-
9) were isolated and tested for their enzymatic activities. All three H. calycinum-derived 
PTs were completely inactive in S. cerevisiae in this study. However, all of them could 
be functionally expressed in Sf9 insect cells and were identified to be xanthone-
specific, i.e. accepting 1,3,7-trihydroxyxanthone (HcPT1) and 1,3,6,7-
tetrahydroxyxanthone (HcPT, HcPT2) as major substrates 112. A similar observation 
was made with PTs isolated from parsley, which were only active in insect cells 84. 
Potential reasons might be a better mRNA stability, more closely related codon usage, 
appropriate glycosylation pattern and chaperon availability, lower protein toxicity, and 
finally a different membrane composition, which enables a better membrane fluidity in 
insect cells 142. Also, synergistic effects might occur. Even omitting the PT signal 
peptide did not lead to a functional expression, as reported elsewhere 143.  
Of all nine H. perforatum-derived PTs expressed in S. cerevisiae, three were found to 
be xanthone-specific (HpPT1, HpPT5, HpPT8) and two were acylphloroglucinol-
specific (HpPT2, HpPT6). More detailed information and further characteristics are 
discussed in the following sections.   
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4.4.1. Xanthone-specific PTs 
Xanthones are plant secondary metabolites present in Hypericum species and others. 
They serve as defense compounds against microorganisms and herbivores and were 
identified to exhibit pharmacological properties such as antibacterial, anti-inflammatory 
and cytotoxic activities 34,144. The biosynthesis starts with the condensation of benzoyl-
CoA with three molecules malonyl-CoA to form 2,4,6-trihydroxybenzophenone. In the 
subsequent reactions, cytochrome P450 monooxygenases catalyze cyclization and 
subsequent 6′-hydroxylation, forming 1,3,6,7-tetrahydroxyxanthone 71,145. Subsequent 
modifications might occur such as hydroxylations and/or prenylations 34,71. HpPT1 and 
HpPT5 were identified to accept 1,3,6,7-tetrahydroxyxanthone and 1,3,7-
trihydroxyxanthone as the preferred substrates using DMAPP (major) and GPP (minor) 
as isoprenoid donors. HpPT8 was found to accept 1,3,6,7-tetrahydroxyxanthone as 
the most preferred substrate using exclusively DMAPP (Table 32, page 73). Besides 
1,3,7-trihydroxyxanthone and 1,3,6,7-tetrahydroxyxanthone, the presence of 
prenylated xanthones such as 1,3,6,7-tetrahydroxy-8-prenylxanthone, 1,3,6,7-
tetrahydroxy-2-prenylxanthone, 1,3,7-trihydroxy-6-methoxy-8-prenylxanthone and 
paxanthone was discovered in H. perforatum cell suspension cultures after treatment 
with Agrobacterium 144.  
Furthermore, a 1,3,6,7-tetrahydroxanthone-specific PT performing a C-8 prenylation 
was characterized in H. calycinum cell cultures after elicitor treatment 34. Therefore, 
the PTs identified during this study might be involved in the prenylation of the xanthone 
derivatives found in H. perforatum. The attachment of one prenyl group to the xanthone 
acceptor has been analyzed by MS spectrometry. Comparing the MS2 fragmentation 
pattern of the HpPT8 product with that of the recently published HcPT product indicates 
identical enzymatic products 34. However, the enzymatic products of HpPT1 and 
HpPT5 should be further analyzed by NMR spectrometry to identify the exact C-
prenylation or C-geranylation positions. All xanthone-specific PTs were not further 
biochemically characterized in this study. Nevertheless, all enzymes show clearly 
plant-derived PT characteristics, such as divalent cation dependency, membrane-
boundness and isoprenoid donor usage. 
Membrane-bound aromatic PTs are originally localized to the envelope membranes of 
the chloroplasts 81,143. Since a yeast cell does not contain any chloroplasts, the PTs 
have to end up in any other membranous organelle like endoplasmic reticulum, Golgi 
and mitochondria or enter the plasmamembrane for functional folding. A GFP_HpPT5 
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translational fusion protein was cloned to localize HpPT5. Similar to previously 
localized PT fusions in insect cells 112, the fluorescence of GFP_HpPT5 was detected 
in the cytoplasm of the yeast cells. Dr. Fiesel (2017) used a H. calycinum-derived PT 
(HcPT), which was expressed in insect cells 112. Thus, the N-terminal transit peptides 
of PTs from different Hypericum species appear to function similarly in the two 
chloroplast-free expression systems. What remains open is the exact intracellular 
localization in which membranous organelle, which awaits further research. 
Potential PT targets for localization might be therefore the membranes of mitochondria, 
endoplasmatic reticulum and Golgi. In this study, no final evidence of a specific 
organelle localization could be obtained. To solve the question regarding the 
localization of PTs within yeast cells other approaches should be realized. A co-
localization expression of an active PT together with a marker protein, which has a 
known target organelle, may be performed. Another possibility is the separation of 
subcellular organelles and performing activity assays using the separated organelle 
fractions. In this context, a geranyl diphosphate:4hydroxybenzoate geranyltransferase 
from Lithospermum erythrorhizon could be localized to the ER in a yeast expression 
system 94. However, it might also form a kind of inclusion bodies due to wrong folding 
events of the PT itself. GFP protein alone is expressed in its functional soluble state.  
The enzymatic activity of the GFP_HpPT5 protein was tested but no activity was 
observed (data not shown). It has been reported that tags can cause non-functional 
expression of a target protein 146. This may involve a HIS-tag but also any other tag 
such as Strep-tag and GFP. Any tags can cause changes in the tertiary structure, 
thereby leading to reduced or even complete loss of activity 146,147. Also, a HIS-tag (N- 
and C-terminal) was tested to purify HpPT5 from solubilized membranes but no activity 
could be detected (data not shown). The same was observed with HpIBS tested in this 
study, as already described before.  
 
 
4.4.2. Phloroglucinol-specific PTs 
Phloroglucinol derivates such as hyperforin possess a number of different 
pharmaceutical activities such as antidepressant properties 118. Hyperforin is a 
polyprenylated acylphlorogucinol derivative with PIBP as the core structure. PIBP is 
formed by the condensation of three molecules of malonyl-CoA and one molecule of 
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isobutyryl-CoA, catalyzed by a type III polyketide synthase (IBS) 118. A series of 
aromatic prenyltransferases was screened for their ability to catalyze the attachment 
of prenyl and geranyl side chains to PIBP. During this study, two consecutive 
acylphlorglucinol-specific PTs (HpPT2 and HpPT6) were biochemically characterized. 
The biochemical investigation of HpPT2 identified a substrate specificity comprising 
several acylphloroglucinol derivatives. The enzyme accepted the skeletons of 
hyperforin, adhyperforin and lupolone, namely PIBP, 2-MBP, and PIVP, respectively. 
Mass- and NMR-based analyses of the enzymatic products revealed the attachment 
of one geranyl group at the C-3 position of the aromatic ring. HPLC analysis of the in 
vitro assays did not yield further geranylated products, i.e. di-geranylated PIBP. 
Regardless of the prenyl-acceptor used, HpPT2 did not accept DMAPP as a prenyl 
donor. This indicates its clear function to perform one geranylation reaction in vivo. 
Consequently, the subsequent series of prenylation reactions are expected to be 
performed by more prenyltransferases to obtain hyperforin and its related analogs. 
The HpPT2 substrate specificity was investigated using a number of Hypericum-
derived constituents including xanthones, flavonoids, acylphloroglucinols, 
benzophenones and phenolic acids as prenyl acceptors as well as DMAPP and GPP 
as prenyl donors (Figure 11, page 43). The highest specificity was found for the 
hyperforin core structure PIBP (100 %), followed by the adhyperforin skeleton 2-MBP 
(70.6 %), 2,3',4,6-tetrahydroxybenzophenone (31.7 %), PIVP (16.9 %), PAP (16.3 %) 
and PBP (5 %) (Figure 33, page 82). The structural differences between the 
acylphloroglucinol derivatives are the acyl side chains, which originate (except for PAP, 
PBP and tetrahydroxybenzophneone) from the amino acids valine, isoleucine, and 
leucine. No further activities were observed with the other potential substrates tested 
in this study. HpPT2 was found to have a high but somewhat broader substrate 
preference for acylphloglucinol derivatives compared to the xanthone-specific PTs 
HpPT1, HpPT5, and HpPT8. The latter PTs were specific for a single major substrate, 
whereas other xanthone derivatives were accepted in the lower percentage range (<10 
%). Similar observations were published for acylphloroglucinol-specific and flavonoid-
specific PTs isolated from hop and Sophora flavescens, respectively 79,80,86,87.      
Besides the substrate specificity, the effects of different divalent cations and pH 
variations were investigated. All PTs used in this study possess the aspartate-rich 
motifs (NQxxDxxxD and KDxxDxxGD), which are required for chelating the divalent 
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cations 112. In contrast to plant-derived PTs, bacterial PTs do not necessarily require 
divalent cations 75. Similarly to recently published plant PTs, HpPT2 prefers Mg2+ as 
the best cation 34,79–81,90,94,148. However, other cations such as Ca2+ and Zn2+ can also 
be accepted by a number of different plant-derived PTs 34,87. One exception has been 
published for a PT from hop, which accepts exclusively Mg2+ as the divalent cation 87. 
All PTs tested during this study failed to show any activity in the presence of EDTA, 
confirming the requirement of cations to perform the catalytic reaction.  
The optimum pH of plant PTs has been reported to be in the alkaline range of 8.0–
10.0, with one exception for a hop-derived PT, which was highly active at pH 7  
34,79,80,87. The optimum pH of HpPT2 was found to be at pH 8, which corresponds to 
the literature data. Also, bacterial PTs were found to exhibit their optimum catalytic 
efficiency at the alkaline pH values 149,150.   
HpPT2 exhibited the highest affinity for 2-MBP (KM = 85 ± 15 µM), whereas that towards 
PIBP was somewhat lower (KM = 124 ± 19 µM). The catalytic velocities observed with 
2-MBP and PIBP were identical (Vmax = 5.1-3 ± 5-4 nmol/mg protein/min). Relatively low 
differences in the kinetic parameters were found for GPPPIBP [KM = 89 ± 35 µM; Vmax = 
7.1-3 ± 9-4 nmol/mg protein/min] and GPP2-MBP [KM = 60 ± 11 µM; Vmax = 4.6-3 ± 3-4 
nmol/mg protein/min]. This suggests that HpPT2 is simultaneously the first enzyme 
involved in the biosynthesis of hyperforin and adhyperforin at the early geranylation 
step, which is also supported by the qPCR data analyzed by Dr. Eline Biedermann and 
Dr. Mariam Gaid 120. Opposite to the proposed pathway of hyperforin biosynthesis, in 
which the first prenylation step is supposed to catalyze the attachment of a C5 unit to 
the aromatic PIBP core, the current study revealed that the first step is the attachment 
of a C10 unit 24. Another hint that GPP might be used as the first isoprenoid donor is 
the presence of 3-geranyl-PIBP in Hypericum species 151. If all PTs involved in 
hyperforin biosynthesis would be also involved in adhyperforin biosynthesis, one would 
expect equal amounts of both constituents in the plant. However, the adhyperforin 
content within the flowering aerial part is only about 10 % of the total hyperforin content 
152. Explanations might be that the catalytic activity and affinity of PTs in the later 
prenylation reactions to accomplish adhyperforin biosynthesis are reduced or the steps 
are taken over by other enzymes. Another bottleneck might be the availability of 2-
methylbutyryl-CoA for starting adhyperforin formation. To some extent, the lower 
availability of the core structure of adhyperfoin might be compensated by the higher 
affinity of HpPT2 towards 2-MBP. In case of higher concentrations of PIBP in H. 
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perforatum, no such high affinity is required. However, higher catalytic activities of 
some enzymes may account for higher hyperforin contents compared to adhyperforin. 
The catalytic activity and affinity values obtained in this study are comparable with 
those reported for other plant PTs. KM values were found in the range between 1 – 220 
µM and catalytic activities in the range of 0.5 – 2 pmol/mg microsomal protein/min 
34,76,80,83,85,87,88,148. The affinity of HpPT2 towards PIVP, which has never been reported 
for Hypericum species, might be an artificial activity due to the structural similarity 
compared to PIBP and 2-MBP.    
A second acylphloroglucinol-specific enzyme is HpPT6, which has been cloned and 
biochemically characterized during this study. For the first time, a PT was identified to 
accept only geranylated acylphloroglucinol derivatives. In addition, HpPT6 shows the 
typical plant-derived PT characteristics regarding the divalent cation dependency, pH 
range, and aspartate-rich motifs. However, there are some biochemical differences 
compared to HpPT2, which might be questionable.  
If HpPT6 would be located within the same chloroplast like HpPT2, it could be assumed 
to have similar biochemical features like HpPT2. Different from HpPT2 and other plant 
PTs, which prefer Mg2+, HpPT6  accepts Ca2+ as the major divalent cation 34,79–
81,90,94,148. Typical of other plant PTs, the pH optimum of HpPT6 is in the alkaline range 
but slightly higher (pH 8 - 9) than HpPT2 (pH 7-8). This difference between HpPT2 and 
HpPT6 may be a hint that the two PTs are not located within the same organelle. It 
would be expected that all PTs located in the chloroplast and involved in hyperforin 
biosynthesis have a close pH optimum to perform the catalytic reaction with high 
activity. The qPCR data obtained by Dr. Eline Biedermann and Dr. Mariam Gaid for 
HpPT6 reveal a higher expression level than for HpPT2 throughout the aerial plant 
organs studied (fruits, flowers, buds and leaves). However, the expression of HpPT6 
was also relatively high in roots, which contain only traces of hyperforin and low HpPT2 
transcript levels.120. Therefore, the involvement of HpPT6 in the hyperforin 
biosynthesis is still somewhat questionable. The lowest KM was detected for 3-G-PIVP 
and 3-G-2-MBP and an approximately doubled activity was observed for 3-G-PIBP.  
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4.5. Genome integration of HpIBCL, HpIBS, HpPT2, and HpPT6 
For the heterologous production of plant secondary metabolites like hyperforin, it is 
necessary to transfer the biosynthetic pathway from the native into the target host, e.g. 
S. cerevisiae. Besides the identification of the enzymes involved in the biosynthetic 
pathway, a number of further aspects must be considered. It is important to regulate 
the gene expression level and the promoter strength must be adjusted; furthermore, 
intracellular regulatory elements might require some modification 23.  
One key element to produce the target molecules is the (over)expression of the 
responsible enzymes. This can be achieved by expressing the genes either plasmid-
based or genome-integrated. To do so, many high copy and low copy plasmids have 
been designed for the successful expression in S. cerevisiae. However, several 
bottlenecks exist in case of plasmid-based expression systems. Firstly, the 
reproducibility of the protein expression is challenging due to the different copy 
numbers of the plasmids. Furthermore, a proper selection marker such as an 
autotrophic or antibiotic marker must be used. These types of plasmids increase the 
costs to produce the target protein. Auxotrophic strains must be cultivated in special 
selection media with (costly) supplements. During the downstream processing, the 
efficient antibiotic removal must be guaranteed. Another disadvantage of using 
episomal expression systems is the loss of plasmids during cultivation for the 
auxotrophic marker. This is caused by the production of the marker itself as well as cell 
death, releasing e.g. uracil which then is available as a complementary compound. 
Consequently, due to plasmid loss, the expression level is dramatically reduced and 
also the reproducibility is fluctuating. Another disadvantage is the number of genes, 
which can be expressed at the same time. Typically, one to two genes can be 
expressed simultaneously, which may limit the expression of complete pathways.   
Nowadays, most of the previously mentioned bottlenecks are overcome by introducing 
the GOIs into the genome of the target organism. Reports prove that the introduction 
of genes into the genome leads to a more homogeneous expression level and 
increases the gene stability within the cells. This guarantees that almost every cell 
within the cultivation population possesses all the genes introduced. Genetic instability 
might occur when the introduced genes share a high sequence homology with native 
genes. Additionally, multi tandem integrations might lead to a loss of the introduced 
genes due to the excision of the genes caused by chromosomal rearrangements. The 
Discussion 
107 
 
major disadvantage might be the lower expression level due to the lower gene number 
present within the cells.    
Hyperforin biosynthesis involves 7–8 enzymes. As described previously, the plasmid-
based expression of all genes might be difficult to establish.  Therefore, the 
implementation of a genome integration protocol was developed, as described by 
Jensen et. al. (2013) during this study 103. Besides the system used in our lab, a number 
of further integration strategies and examples have been published 10,18,23,98–
100,102,125,153–155. A GFP protein was chosen as an example gene to establish the 
protocol. The GFP gene was successfully integrated, as described elsewhere (data 
not shown) 119. Afterwards, HpIBCL and HpIBS were successfully integrated and the 
product could be detected (Figure 40, page 91). However, it was not possible to 
quantify the product amount due to the high amount of impurities. Comparing the 
product amount generated by the yeast strain containing HpIBCL and HpIBS as 
integrated into the genome, a much lower product amount could be detected in the 
medium. The major reason might be the lower copy number, only one copy per yeast 
cell is present, compared to about 20 – 40 plasmid copies per cell using plasmid-based 
protein expression. Furthermore, the experiments must be repeated and the 
quantification method improved. Both PT enzymes HpPT2 and HpPT6 were 
additionally integrated into the genome to the same strain before (Figure 43, page 99). 
Only traces of the HpPT2 product could be detected in the HPLC-DAD chromatogram 
(data not shown). So far, no MS data were prepared to validate the correct product 
formed. This needs to be confirmed in the future perspectives.  
To summarize, it was possible to successfully implement the genome integration 
protocol in our laboratory. Both GFP and HpIBCL_HpIBS were actively integrated. This 
protocol can be further used for the implementation and improvement of further genes 
as well as for the cultivation.         
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4.6. Conclusion and Outlook 
In this study, a cascade consisting of four consecutive enzymes was identified and 
functionally expressed in yeast, enabling the generation of the hyperforin precursor 
molecule 3-geranyl-5-prenyl-PIBP (Figure 44). This cascade includes the isobutyryl-
CoA ligase together with an isobutyrophenone synthase for the biosynthesis of the 
hyperforin skeleton PIBP. The two genes were expressed both episomally and 
integrated into the yeast genome. By feeding isobutyric-acid, the PIBP product could 
be produced and was detected in both expression systems at detectable 
concentrations. 
   
 
Figure 44. Enzyme cascade towards hyperforin formation, which was functionally expressed in S. 
cerevisiae and tested under in vivo and/or in vitro conditions. Modified from Beerhues (2006) 24. 
 
In total, 12 different PTs have been investigated for their functional expression and 
biochemical characteristics.  Finally, three xanthone-specific and two acylphlorglucinol-
specific PTs were identified. Especially the latter acylphlorglucinol-specific PTs 
(HpPT2 and HpPT6) are particularly interesting for the hyperforin biosynthesis.  
HpPT2 transfers a geranyl side chain to the hyperforin core structure PIBP, forming 3-
geranyl-PIBP. Subsequently, this product is used by HpPT6 as a substrate, hereby 
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attaching another prenyl side chain, forming the hyperforin precursor molecule 3-
geranyl-5-prenyl-PIBP. All actively expressed PTs show typical plant-specific PT 
characteristics. This includes dependency on divalent cations, highest activity at 
slightly alkaline pH values, and acceptance of geranyl and/or prenyl moieties. In 
addition, the two fully characterized acylphloroglucinol-specific PTs exhibited a 
relatively broad substrate specificity.  
The kinetic data obtained for HpPT2 showed the highest affinity and catalytic velocity 
to the basic structures of adhyperforin and hyperforin. In conclusion, it is suggested 
that HpPT2 is involved in adhyperforin and hyperforin biosynthesis. The kinetic data of 
HpPT6 showed the highest affinity towards the adhyperforin and colupolone 
precursors. A slightly lower affinity and catalytic rate were observed for the hyperforin 
precursor.  
As an outlook, it should be mentioned that the missing PTs still have to be identified in 
order to complete the hyperforin biosynthesis. This is the current challenge because 
no PTs have so far been isolated using polyprenylated acylphloroglucinol derivatives 
as substrates. Also, the possibility that multiple PTs form a catalytic complex 
(metabolon) should be considered, finishing the hyperforin biosynthesis. Such an 
example has recently been published for the completion of colupolone biosynthesis 86. 
In addition, it is still unclear how the last cyclization step in hyperforin biosynthesis 
takes place. Therefore, the corresponding enzyme still has to be identified. After the 
complete biosynthesis has been successfully identified, the whole pathway should be 
preferably integrated into the yeast genome. Moreover, the 3-geranyl-5-prenyl-PIBP 
product is already proved to be unstable. Therefore, it might represent another 
challenge to stabilize the biosynthetic hyperforin intermediates and hyperforin itself.  
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6.3. List of Abbreviations and Denotation 
Abbreviation Denotation 
°C Grad Celsius 
µL Microliter 
µM Micromolar 
2-MBP 2-Methylbutanoyl-phloroglucinol  
3-G-X 3-geranyl-X 
abs. absolute  
ADP Adenosine diphosphate 
AP Alkaline Phosphatase 
ATP Adenosine-triphosphate 
bp  Base pair(s) 
BPS Benzophenone synthase 
BSA Bovine serum albumin 
BZCL Benzoate-CoA-Ligase  
CaCl2 Calcium chloride 
cm centimeter 
CoA Coenzyme-A 
DAD Diode Array Detector 
ddH2O  Double-distilled water 
DMAPP Dimethylallyl pyrophosphate 
DMSO  Dimethylsulfoxid 
DNA  Deoxyribonucleic acid 
dNTP  Deoxynucleotide triphosphate 
E. coli  Escherichia coli 
e.g.  exempli gratia (for example) 
EDTA Ethylenediaminetetraacetic acid 
EPI Enhanced Product Ion 
epi. episomal 
ESI Electrospray-Ionization  
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et al. et alii 
EtOAc  Ethyl acetate 
EtOH  Ethanol 
EV  Empty vector 
Fig.  Figure 
fw forward 
g Gramm 
g  Gravitational force 
g/L  gram per liter  
Gal D-Galactose 
GFP Green Fluorescent Protein 
gint.  genome integration  
GOI  Gene of interest 
GPP Geranyl pyrophosphate 
h  Hour(s) 
HaCHS Hypericum androsaemum Chalcone synthase 
HaPT Hypericum androsaemum Prenyltransferase  
HBr Hydrogen Bromide  
HCl hydrochloride  
HcPT Hypericum calycinum Prenyltransferase  
HIS Histidine  
HpIBS Hypericum perforatum Isobutyrophenone synthase 
HPLC  High performance liquid chromatography 
HpPT Hypericum perforatum Prenyltransferase  
IBCL Isobutyrate-CoA ligase  
IBS Isobutyrophenone synthase 
INVSC1 Invitrogen S. cerevisiae No. 1 
IPTG Isopropyl β-D-1-thiogalactopyranoside 
kb  Kilobase(s) 
kcat  Catalytic activity 
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Km Michaelis Menten constant/substrate affinity constant 
KPi-buffer Potassium phosphate buffer 
LB-medium Luria-Bertani-medium 
LC Liquid chromatography 
m/z  Mass-to-charge ratio 
MCS  Multiple cloning sites 
MeOH Methanol  
MG Monogeranylated  
MgCl2 Magnesium chloride 
min  minute(s) 
ml milliliter 
mL/L milli liter per liter 
mM  milli molar 
mRNA  Messenger ribonucleic acid 
MS  Mass spectrometry 
MS2  Tandem Mass spectrometry 
MW Molecular Weight  
N2 Nitrogen 
NaCl Sodium chloride 
NaOH Natriumhydroxid 
ng nanogram 
nm nanometer 
NMR-spectrometry Nuclear magnetic resonance spectrometry 
nt  Nucleotide 
OD Optical density 
OD600  Optical density at a wavelength of 600 nm 
PAGE Polyacrylamide gel electrophoresis 
PAP Phloracetophenone 
PBP Phlorbenzophenone 
PCR  Polymerase chain reaction 
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PEG Polyethylenglycol 
pH  
Decimal logarithm of the reciprocal of the hydrogen ion 
activity 
PIBP Phlorisobutyrophenone  
PIVP Phlorisovalerophenone 
PKS Polyketide synthase 
PPAP Polycyclic polyprenylated acylphloroglucinol 
PT Prenyltransferase  
Rec. Recombinant  
Ref.  Reference 
RNA Ribonukleinsäure 
RP Reverse Phase  
rpm  Revolutions per minute 
RT  Room temperature 
rv Reverse 
s  Second(s) 
S. cerevisiae Saccharomyces cerevisiae 
SDS-PAGE Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
sec Sekunde 
SGI-medium Synthetic minimal medium 
SNP  Single Nucleotide Polymorphism 
TAE Tris-Acetate-EDTA 
Taq-polymerase Thermus aquaticus-polymerase 
TBS Tris-buffered saline 
temp.  temperature  
Tm Melting Temperature 
TRIS Tris-(hydroxymethyl)-aminomethane 
U  Units (enzyme activity) 
URA Uracil 
USER Uracil-Specific Excision Reagent 
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UV  Ultraviolet 
V Volt 
v/v  volume per volume 
VIS Visible  
Vmax Maximum Velocity 
vs. versus 
w/v  weight per volume 
w/w  weight per weight 
wt Wild-type 
YPSE Yeast peptone sucrose ethanol 
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6.4. Oligonucleotides 
 
Oligonucleotide sequences used in this thesis are not shown to maintain confidentiality until manuscript publication.  
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6.5. DNA Sequences 
 
Nucleotide sequences for enzymes used in this thesis are not shown to maintain 
confidentiality until manuscript publication.  
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6.6. Calibration Curves 
 
 
Figure 45: Calibration curve of chemically synthesized phlorisobutyrophenone. The coefficient of 
determination was calculated to be R² = 0.9908 from 0.1 to 10 µg phlorisobutyrophenone. 
 
 
 
Figure 46: Calibration curve of chemically synthesized 3-geranyl-phlorisobutyrophenone. The coefficient 
of determination was calculated to be R² = 0.9999 from 0.1 to 10 µg 3-geranyl-phlorisobutyrophenone. 
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Figure 47: Calibration curve of chemically synthesized 3-geranyl-2 methylbutanoyl-phloroglucinol. The 
coefficient of determination was calculated to be R² = 0.9994 from 0.1 to 10 µg 3-geranyl-2 
methylbutanoyl-phloroglucinol. 
 
 
 
Figure 48: Calibration curve of chemically synthesized 3-geranyl-phlorisovalerophenone. The coefficient 
of determination was calculated to be R² = 0.9999 from 0.1 to 10 µg PIBP 3-geranyl-
phlorisovalerophenone. 
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Figure 49: Calibration curve of chemically synthesized 3-geranyl-phloracetophenone. The coefficient of 
determination was calculated to be R² = 1 from 0.1 to 10 µg 3-geranyl-phloracetophenone. 
 
 
 
Figure 50: Calibration curve of chemically synthesized 3-geranyl-phlorbenzophenone. The coefficient of 
determination was calculated to be R² = 0.9999 from 0.1 to 10 µg 3-geranyl-phlorbenzophenone. 
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6.7. NMR Data 
 
6.7.1. 1H NMR data of chemically synthesized phlorisobutyrophenone 
 
Figure 51: 1H-NMR data for chemically synthesized phlorisobutyrophenone. 
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6.7.2. 1H and 13C-NMR data of chemically synthesized 2-methylbutanoyl-
phloroglucinol 
 
 
Figure 52: 1H-NMR data for chemically synthesized 2-methylbutanoyl-phloroglucinol. 
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Figure 53: 13C-CPD NMR data for chemically synthesized 2-methylbutanoyl-phloroglucinol. 
 
 
Figure 54: 13C-Dept 135 NMR data for chemically synthesized 2-methylbutanoyl-phloroglucinol. 
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6.7.3. 1H and 13C-NMR data of chemically synthesized phlorisovalerophenone 
 
Table 35: NMR data of grr133194 [CAS: 26103-97-9] 
Position 13C DEPT 1H 
1 104.0 Cq   
2, 6 164.2 Cq   
2-, 6-OH - - 12.25 (s, 2 H) 
3, 5 94.6 CH 5.80 (s) 
4 164.5 Cq   
4-OH - - 10.34 (s, 1 H) 
7 204.8 Cq   
8 51.9 CH2 2.86 (d, 6.8 Hz, 2 H) 
9 24.8 CH 2.14 (nonet, 6.7 Hz, 1 H) 
10, 11 22.6 2 CH3 0.91 (d, 6.7 Hz, 6 H) 
a Measuring frequencies: 500.3 MHz (1H), 125.8 MHz (13C); solvent: DMSO-d6; 
references: tetramethylsilane (H = 0.00 ppm), solvent (C = 39.50 ppm). 
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Figure 55: 1H-NMR data for the chemically synthesized phlorisovalerophenone. 
 
 
 
Figure 56: 13C-CPD NMR data for the chemically synthesized phlorisovalerophenone. 
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Figure 57: 13C-Dept 135 NMR data for the chemically synthesized phlorisovalerophenone. 
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6.7.4. 1H and 13C-NMR data for chemically synthesized 3-prenyl-
phlorisobutyrophenone 
 
Table 36: NMR data of grr133195a,b [CAS No. 35932-36-6] 
Position 13C DEPT 1H HMBCc 
1 102.6 Cq  2-OH, 3, 6-OH 
2 159.5 Cq  (2-OH), 3 
2-OH - - 10.53 (s, 1 H)   
3 94.2 CH 5.99 (s, 1 H) (2-OH), (4-OH) 
4 162.1 Cq  3, 4-OH, (6-OH), 1" 
4-OH - - 10.28 (s, 1 H)   
5 105.9 Cq  3, 4-OH, 6-OH, 1" 
6 163.8 Cq  6-OH, 1" 
6-OH - - 14.15 (s, 1 H)   
7 209.5 Cq  8, 9, 10 
8 38.1 CH 3.90 (sept, 6.7 Hz, 1 H) 9, 10 
9, 10 19.3 2 CH3 1.07 (d, 6.7 Hz, 6 H) 8, 9, 10 
1" 21.0 CH2 3.07 (br. d, 7.1 Hz, 2 H)   
2" 123.4 CH 5.11 (t x sept, 7.1, 1.4 Hz, 1 H) 1", 4"E, 4"Z 
3" 129.5 Cq  1", 4"E, 4"Z 
4"E 25.5 CH3 1.59 (br. d, 1.3 Hz, 3 H) 2", 4"Z 
4"Z 17.6 CH3 1.68 (br. d, 1.2 Hz, 3 H) 2", 4"E 
a Measuring frequencies: 500.3 MHz (1H), 125.8 MHz (13C); solvent: DMSO-d6; references: 
tetramethylsilane (H = 0.00 ppm), solvent (C = 39.50 ppm). 
b For previous NMR data, see Boubakir et al. (2005). The present data and assignments are more 
complete. 
c Entries in the HMBC column indicate 1H nuclei showing long-range correlations 
with the 13C chemical shift in the second column. Weak correlations in parentheses. 
Z. Boubakir, T. Beuerle, B. Liu, L. Beerhues (2005) Phytochemistry 66, 51–57. 
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Figure 58: 1H-NMR data for the chemically synthesized 3-prenyl-phlorisobutyrophenone. 
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Figure 59: 13C-CPD NMR data for the chemically synthesized 3-prenyl-phlorisobutyrophenone 
 
 
 
Figure 60: 13C-Dept 135 NMR data for the chemically synthesized 3-prenyl-phlorisobutyrophenone 
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6.7.5. 1H and 13C-NMR data of chemically synthesized 3-geranyl-2-
methylbutanoyl-phloroglucinol 
 
Table 37: NMR data of grr133479a, b [CAS No. 72008-04-9] 
Position 13C DEPT 1Hc HMBCd 
1 103.1 Cq  5, 2-OH, 6-OH 
2 163.7 Cq  2-OH, (4-OH), (6-OH), 1' 
2-OH - - 14.21 (s, 1 H)   
3 105.9 Cq  2-OH, 4-OH, 5, 1' 
4 162.0 Cq  (2-OH), 4-OH, 1' 
4-OH - - 10.27 (s, 1 H)   
5 94.1 CH 5.99 (s, 1 H) 4-OH, 6-OH 
6 159.5 Cq  5, 6-OH 
6-OH - - 10.50 (s, 1 H)   
7 209.1 Cq  (5), 8, 9 (both H), 11 
8 44.6 CH 3.79 (sext, 6.7 Hz, 1 H) 9 (both H), 10, 11 
9 26.4 CH2 1.72 (dqd, 13.3, 7.4, 6.4 Hz, 1 H) 
1.31 (dqd, 13.3, 7.4, 6.9 Hz, 1 H) 
8, 10, 11 
10 11.8 CH3 0.84 (t, 7.4 Hz, 3 H) 8, 9 (both H) 
11 16.7 CH3 1.06 (d, 6.8 Hz, 3 H) 8, 9 (both H) 
1' 20.8 CH2 3.08 (br. d, 7.1 Hz, 1') (5), 2' 
2' 123.1 CH 5.12 (t x sext, 7.1, 1.3 Hz, 1 H) 1', 4', 9' 
3' 133.0 Cq  1', 4', (5'), 9' 
4' 39.2 CH2 1.89 ("t", ca. 7.6 Hz, 1 H) 2', 5', 9' 
5' 26.1 CH2 1.98 ("q", ca. 7.2 Hz, 1 H) 4', (6') 
6' 124.1 CH 5.03 (t x sept, 7.1, 1.4 Hz, 1 H) 4', 5', 8'E, 8'Z 
7' 130.5 Cq  5', 8'E, 8'Z 
8'E 25.4 CH3 1.59 (br. d, 1.3 Hz, 3 H) 6', 8'Z 
8'Z 17.4 CH3 1.52 (br. d, 0.9 Hz, 3 H) 6', 8'E 
9' 15.8 CH3 1.69 (br. d, 1.3 Hz, 3 H) 2', 4' 
a Measuring frequencies: 600.1 MHz (1H), 150.9 MHz (13C); solvent: DMSO-d6; references: 
tetramethylsilane (H = 0.00 ppm), solvent (C = 39.50 ppm). 
b For previous NMR data, see Schmidt et al. (2012): good data, solvent 
CDCl3. 
c Some important H,H-NOEs: 1'-9'; 2'-1', 4'; 4'-9'; 5'-4', 8'Z, 9'; 6'-(5'), 8'E. 
d Entries in the HMBC column indicate 1H nuclei showing long-range correlations with the 13C chemical 
shift in the second column. Weak correlations in parentheses. 
S. Schmidt, G. Jürgenliemk, H. Skaltsa, J. Heilmann (2012) Phytochemistry 
77, 218–225 
Appendix 
153 
 
 
 
 
Figure 61: 1H-NMR data for the chemically synthesized 2-methylbutanoyl-phloroglucinol. 
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Figure 62: 13C-CPD NMR data for the chemically synthesized 2-methylbutanoyl-phloroglucinol. 
 
 
Figure 63: 13C-Dept 135 NMR data for the chemically synthesized 2-methylbutanoyl-phloroglucinol. 
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6.7.6. 1H and 13C-NMR data for chemically synthesized 3-geranyl-
phlorisovalerophenone 
 
Table 38: NMR data of grr133197a, b [CAS No. 144785-80-8] 
Position 13C DEPT 1H HMBCc 
1 105.1 Cq  5 
2 162.5 Cq  1' 
3 105.5 Cq  5, 1' 
4 160.8 Cq  5, 1' 
5 95.3 CH 5.83 (s, 1 H) - 
6 160.0 Cq  5 
7 205.9 Cq  8 
8 52.9 CH2 2.94 (d, 6.7 Hz, 2 H) 9, 10, 11 
9 25.2 CH 2.26 (nonet, 6.7 Hz, 1 H) 8, 10, 11 
10, 11 22.8 CH3 0.97 (d, 6.7 Hz, 6 H) 8, 9, 10, 11 
1' 21.6 CH2 3.37 (br. d, 7.2 Hz, 2 H) (2') 
2' 121.5 CH 5.25 (t x sext, 7.2, 1.3 Hz, 1 H) 1', 4'/5', 9' 
3' 140.1 Cq  1', 4'/5', 9' 
4' 39.7 CH2 2.14-2.06 (m, 2 H) 2', 5', 9' 
5' 26.3 CH2 2.14-2.06 (m, 2 H) 4' 
6' 123.6 CH 5.05 (t x sept, 6.9, 1.4 Hz, 1 H) 4'/5', 8'E, 8'Z 
7' 132.2 Cq  4'/5', 8'E, 8'Z 
8'E 25.7 CH3 1.68 (br. d, 1.2 Hz, 3 H) (6'), 8'Z 
8'Z 17.7 CH3 1.60 (br. d, 0.9 Hz, 3 H) (6'), 8'E 
9' 16.2 CH3 1.82 (q, 1.3 Hz, 3 H) 2', 4'/5' 
a Measuring frequencies: 500.3 MHz (1H), 125.8 MHz (13C); solvent: CDCl3; references: 
tetramethylsilane (H = 0.00 ppm), solvent (C = 77.01 ppm). 
b For previous NMR data, see Rios and Delgado (1992). Their 1H NMR data are  
incomplete and the 13C NMR spectrum was taken from a 3:3:1-mixture of  
three compounds. 
c Entries in the HMBC column indicate 1H nuclei showing long-range correlations  
with the 13C chemical shift in the second column. Weak correlations in parentheses. 
4’/5’ stands for 4’ and/or 5’. 
M. Y. Rios, G. Delgado (1992) Phytochemistry 31, 3491–3494 
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Figure 64: 1H-NMR data for the chemically synthesized 3-geranyl-phlorisovalerophenone. 
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Figure 65: 13C-CDP NMR data for the chemically synthesized 3-geranyl-phlorisovalerophenone. 
 
 
 
Figure 66: 13C-Dept 135 NMR data for the chemically synthesized 3-geranyl-phlorisovalerophenone. 
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6.7.7. 1H and 13C-NMR data for chemically synthesized 3-geranyl-
phloracetophenone 
 
Table 39: NMR data of grr133196a, b [CAS No. 43230-43-9] 
Position 13C DEPT 1H HMBCc, d 
1 105.2 Cq  5, 8 
2 162.4 Cq  1' 
3 105.4 Cq  5, 1', (2') 
4 161.2 Cq  5, 1' 
5 95.3 CH 5.86 (s, 1 H)   
6 160.4 Cq  5 
7 203.6 Cq  (5), 8 
8 32.9 CH3 2.67 (s, 3 H)   
1' 21.5 CH2 3.37 (dd, 7.2, 0.4 Hz, 2 H) (5), 2' 
2' 121.4 CH 5.25 (t x sext, 7.2, 1.3 Hz, 1 H) 1', 4'/5', 9' 
3' 140.1 Cq  1', 4'/5', 9' 
4' 39.7 CH2 2.13-2.07 (m, 2 H) 2', 5', (6'), 9' 
5' 26.2 CH2 2.13-2.07 (m, 2 H) 4', 6' 
6' 123.6 CH 5.05 (t x sept, 7.0, 1.4 Hz, 1 H) 4'/5', 8'E, 8'Z 
7' 132.2 Cq  4'/5', 8'E, 8'Z 
8'E 25.7 CH3 1.68 (br. d, 1.2 Hz, 3 H) 6', 8'Z 
8'Z 17.7 CH3 1.60 (br. d, 0.9 Hz, 3 H) 6', 8'E 
9' 16.2 CH3 1.81 (br. d, 1.3 Hz, 3 H) 2', 4'/5' 
a Measuring frequencies: 500.3 MHz (1H), 125.8 MHz (13C); solvent: CDCl3; references: 
tetramethylsilane (H = 0.00 ppm), solvent (C = 77.01 ppm). 
b For previous NMR data, see Basabe et al. (2010). Their 13C NMR spectrum is unassigned and  
has inconsistencies in the Car–O region, similarly in Lee et al. (2008). 
c Entries in the HMBC column indicate 1H nuclei showing long-range correlations with the 13C chemical 
shift in the second column. Weak correlations in parentheses. 4’/5’ etc. stands for 4’ and/or 5’. 
d Experiment carried out with NUS (non-uniform sampling with a data sample of 50 per cent). 
P. Basabe, M. de Román, I. S. Marcos, D. Diez, A. Blanco, O. Bodero, F. Mollinedo, B. G. Sierra, J. G. 
Urones (2010) Eur. J. Med. Chem. 45, 4258–4269. Y. R. Lee, X. Li, J. H. Kim (2008) J. Org. Chem. 
73, 4313–4316. 
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Figure 67: 1H-NMR data for the chemically synthesized 3-geranyl-phloracetophenone. 
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Figure 68: 13C-CPD NMR data for the chemically synthesized 3-geranyl-phloracetophenone. 
 
 
 
Figure 69: 13C-Dept 135 NMR data for the chemically synthesized 3-geranyl-phloracetophenone. 
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6.7.8. 1H and 13C-NMR data for chemically synthesized 3-geranyl-
phlorbenzophenone 
 
Table 40: NMR data of grr133480a, b [CAS No. 70219-87-3] 
Position 13C DEPT 1Hc HMBCd 
1 104.5 Cq - 2-OH, 5 
2 160.8 Cq - (2-OH), 1' 
2-OH   10.28 (s, 1 H)   
3 106.5 Cq - 2-OH, 5, 1' 
4 162.8 Cq - 5, 1' 
5 96.2 CH 5.94 (s, 1 H) - 
6 159.4 Cq - 5 
7 197.8 Cq - (5), 9, 13 
8 140.1 Cq - 10, 12 
9, 13 127.9 2 CH 7.64 ("d", 2 H) 9, (10), (11), (12), 13 
10, 12 129.0 2 CH 7.50 ("t", 2 H) 10, 12 
11 132.1 CH 7.57 ("t", 1 H) 9, 13 
1' 21.6 CH2 3.37 (br. d, 7.1 Hz, 2 H) (5), 2' 
2' 121.5 CH 5.26 (t x sext, 7.1, 1.4 Hz, 1 H) 1', (4'), 9' 
3' 139.2 Cq - 1', 4', 9' 
4' 39.7 CH2 2.07 (m, 2 H) (1'), 2', 5', 9' 
5' 26.3 CH2 2.10 (m, 2 H) 4', (6') 
6' 123.7 CH 5.05 (t x sept, 6.8, 1.4 Hz, 1 H) (5'), 8'E, 8'Z 
7' 132.1 Cq - 8'E, 8'Z 
8'E 25.7 CH3 1.66 (br. d, 1.2 Hz, 3 H) 6', 8'Z 
8'Z 17.7 CH3 1.59 (br. d, 0.9 Hz, 3 H) 6', 8'E 
9' 16.2 CH3 1.79 (br. d, 1.3 Hz, 3 H) 2', 4' 
a Measuring frequencies: 600.1 MHz (1H), 150.9 MHz (13C); solvent: CDCl3; references: 
tetramethylsilane (H = 0.00 ppm), solvent (C = 77.01 ppm). 
b For previous 1H NMR data, see Bohlmann and Suwita (1980). Their assignments of protons 8’E and 
8’Z should be interchanged. 
c Some important H,H-NOEs: 1'-9'; 2'-1', 4', (5'); 4'-9'; 5'-8'Z, 9'; 6'-4', 5', 8'E. 
d Entries in the HMBC column indicate 1H nuclei showing long-range correlations with the 13C chemical 
shift in the second column. Weak correlations in parentheses. 
F. Bohlmann, A. Suwita (1980) Phytochemistry 19, 683–684 
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Figure 70: 1H-NMR data for the chemically synthesized 3-geranyl-phlorbenzophenone. 
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Figure 71: 13C-CPD NMR data for the chemically synthesized 3-geranyl-phlorbenzophenone. 
 
 
Figure 72: 13C-Dept 135 NMR data for the chemically synthesized 3-geranyl-phlorbenzophenone. 
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6.7.9. 1H and 13C-NMR data of the HpPT2 product from incubation with 
phlorisobutyrophenone and GPP  
 
Table 41: 1H and 13C nuclear magnetic resonance (NMR) data of 3-geranyl-2,4,6-tri-
hydroxyisobutyrophenone (1) in CDCl3 
 
Position 13Ca 1Ha,b HMBCc,d 
1 104.1 - (5) 
2 162.8 - 11 
3 105.8 - (5), 11, 12, (20) 
4 160.8 - (5), 11 
5 95.3 5.89 (s, 1 H) - 
6 159.8 - (5) 
7 210.6 - 8, 9/10 
8 39.2 3.89 (sept, J = 6.7 Hz, 1 H) 9/10 
9, 10 19.3 1.17 (d, J = 6.7 Hz, 6 H) 8, 9/10 
11 21.6 3.36 (d, J = 7.2 Hz, 2 H) 12 
12 121.6 5.25 (t x sext, J = 7.2, 1.2 Hz, 1 H) 11, (14), 20 
13 139.5 - 11, 14, 20 
14 39.7 2.10 (m, 2 H) 12, 15, 20 
15 26.3 2.06 (m, 2 H) 14, 16 
16 123.7 5.05 (t x sept, J = 6.8, 1.4 Hz, 1 H) 15, 18, 19 
17 132.1 - (15), 18, 19 
18 25.7 1.67 (d, J  1.1 Hz, 3 H) 16, 19 
19 17.7 1.59 (br. s, 3 H) (16), 18 
20 16.2 1.81 (br. s, 3 H) 12, 14 
a Chemical shifts in ppm: C relative to CDCl3 ( = 77.01 ppm) and H relative to TMS ( = 0.00 ppm). 
b H of OH protons at 11.9, 8.7 and 6.5 ppm, broad signals, unassigned. 
c Entries in the HMBC column indicate 1H nuclei showing long-range correlations with the 13C chemical 
shift in the second column. 
d Weak correlations in parentheses. 
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6.7.10. 1H and 13C-NMR data of the HpPT2 product from incubation with 
phlorisobutyrophenone and DMAPP 
 
Table 42: NMR data of gam129944a, b (“DP_PiBP4”) [CAS No. 72008-03-8] 
Position 
13C DEPT 1Hc HMBCd 
1 104.2 Cq - 5 
2 162.6 Cq - 1' 
3 105.6 Cq - 1', 5 
4 160.7 Cq - 1', 5 
5 95.5 CH 5.83 (s, 1 H) - 
6 159.7 Cq - 5 
7 210.5 Cq - (8), 9, 10 
8 39.3 CH 3.88 (sept, 6.7 Hz, 1 H) 9, 10 
9, 10 19.3 2 CH3 1.18 (d, 6.7 Hz, 6 H) 8, 9, 10 
1' 21.6 CH2 3.38 (br. d, 7.2, 2 H) (2') 
2' 121.4 CH 5.26 (t x sext, 7.2, 1.2 Hz, 1 H) 1, 4', 9' 
3' 140.2 Cq - 1, 4', 9' 
4' 39.7 CH2 2.09 (m, 2 H) (2'), 5', 9' 
5' 26.3 CH2 2.11 (m, 2 H) 4' 
6' 123.6 CH 5.05 (t x sept, 7.2, 1.2 Hz, 1 H) 5', 8'E, 8'Z 
7' 132.2 Cq - (5'), 8'E, 8'Z 
8'E 25.7 CH3 1.68 (q, 1.1 Hz, 3 H) (6'), 8'Z 
8'Z 17.7 CH3 1.60 (br. “s”, 3 H) 8'E 
9' 16.2 CH3 1.82 (q, 1.1 Hz, 3 H) (2'), (4') 
a Measuring frequencies: 600.1 MHz (1H), 150.9 MHz (13C); solvent: CDCl3; references: 
tetramethylsilane (H = 0.00 ppm), solvent (C = 77.01 ppm). 
b For previous 1H NMR data, see Bohlmann and Zdero (1979); their H values differ by 0.05–0.06 ppm 
from ours and their 8’E/8’Z-assignments should be interchanged. 
c H,H-COSY cross-peaks: 8 – 9, 10; 1’ – 4’, 9’; 2’ – 1’, 4’, 9’; 4’ – (9’); 5’ – 8’E, 8’Z; 6’ – 5‘, 8’E, 8’Z. 
d Entries in the HMBC column indicate 1H nuclei showing long-range correlations with the 13C chemical 
shift in the second column. Weak correlations in parentheses. 
F. Bohlmann, C. Zdero (1979) Phytochemistry 18, 641–644. 
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6.7.11. 1H and 13C-NMR data of the HpPT6 product from incubation with 3-
geranyl-phlorisobutyrophenone and DMAPP  
 
Table 43: NMR data of grr132394a  
Position 13Cb DEPTc 1Hd HMBCe 
1  Cq -  
2  Cq -  
2-OH - -   
3  Cq -  
4  Cq -  
4-OH - -   
5  Cq -  
6  Cq -  
6-OH - -   
7 210.6 Cq - 8, 9, 10 
8 38.4 CH 3.98 (sept, 6.8 Hz, 1 H) 9, 10 
9, 10 19.5 2 CH3 1.09 (d, 6.8 Hz, 6 H) 8, 9, 10 
1', 1" 21.5 2 CH2 3.24 (br. d, 6.7 Hz, 4 H) (2, 2") 
2' 123.0 CH 5.05 (m, 1 H) 1', 4', 9' 
3' 133.7 Cq - 1', 4', 9' 
4' 39.3 CH2 1.90 (m, 2 H) (2'), (9') 
5' 26.1 CH2 1.99 (m, 2 H) 4' 
6' 124.1 CH 5.04 (m, 1 H) 4', 5', 8'E, 8'Z 
7' 130.6 Cq - 5', 8'E, 8'Z 
8'E 25.46 CH3 1.59 (br. d, 1.3 Hz, 3 H) 8'Z 
8'Z 17.5 CH3 1.52 (br. d, 1.1 Hz, 3 H) 6', 8'E 
9' 16.0 CH3 1.70 (br. d, 1.3 Hz, 3 H) 2', 4' 
2" 123.3 CH 5.04 (m, 1 H) 1", 4"E, 4"Z 
3" 130.1 Cq - 1", 4"E, 4"Z 
4"E 25.51 CH3 1.61 (br. d, 1.3 Hz, 3 H) 4"Z 
4"Z 17.8 CH3 1.69 (br. d, 1.1 Hz, 3 H) 2", 4"E 
a Measuring frequencies: 600.1 MHz (1H), 150.9 MHz (13C); solvent: DMSO-d6; references: 
tetramethylsilane (H = 0.00 ppm), solvent (C = 39.50 ppm). 
b Due to lack of material 13C chemical shifts had to be taken from the 2D HSQC and HMBC spectra. 
c DEPT information from a multiplicity-edited HSQC spectrum. 
d Some important H,H-COSY crosspeaks: 2' - 1', 9'; 6'/2" - 1", 4"E, 4"Z, 8'E, 8'Z; 8 - 9, 10; 1'/1" - 4', 4"E, 
4"Z; 5' - 4', 8'E, 8'Z; 4' - (9'); 8 - 9, 10. 
e Entries in the HMBC column indicate 1H nuclei showing long-range correlations  
with the 13C chemical shift in the second column. Weak correlations in parentheses. 
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Figure 73: 1H-NMR data of the enzymatic product 3-geranyl-5-prenyl-phlorisobutyrophenone. 
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Figure 74: 13C-CPD NMR data data of the enzymatic product 3-geranyl-5-prenyl-
phlorisobutyrophenone. 
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